IKKA
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0MZ66 | S444 | Sugiyama | SHTN1 KIAA1598 | RPVNQTARPKTKPESSKGCEsAVDELKGILGtLNKSTSSRs |
| A0MZ66 | S467 | Sugiyama | SHTN1 KIAA1598 | DELKGILGtLNKSTSSRsLKsLDPENsEtELERILRRRKVt |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| A6NKT7 | S980 | Sugiyama | RGPD3 RGP3 | GVIFGQTSSTFTFADVAKstsGEGFQFGKKDLNFKGFSGAG |
| O00273 | S37 | Sugiyama | DFFA DFF1 DFF45 H13 | TLKPCLLRRNysREQHGVAAsCLEDLRSKACDILAIDKSLT |
| O00429 | S44 | Sugiyama | DNM1L DLP1 DRP1 | QLPQIVVVGTQSSGKSsVLEsLVGRDLLPRGTGIVTRRPLI |
| O14545 | S320 | Sugiyama | TRAFD1 FLN29 | YPEELLIDHQTSCNPSRALPsLNtGsssPRGVEEPDVIFQN |
| O14545 | S409 | Sugiyama | TRAFD1 FLN29 | CDQRPATATNHVTEGIPRLDsQPQEtsPELPRRRVRHQGDL |
| O14715 | S979 | Sugiyama | RGPD8 RANBP2ALPHA RANBP2L1 RANBP2L3 | GVIFGQTSSTFTFADVAKstsGEGFQFGKKDLNFKGFSGAG |
| O14920 | S177 | SIGNOR|ELM | IKBKB IKKB | EQRLIHKIIDLGYAKELDQGsLCTsFVGTLQyLAPELLEQQ |
| O14920 | S181 | SIGNOR|ELM | IKBKB IKKB | IHKIIDLGYAKELDQGsLCTsFVGTLQyLAPELLEQQKyTV |
| O14920 | S670 | ELM | IKBKB IKKB | RQKELWNLLKIACSKVRGPVsGsPDsMNAsRLsQPGQLMsQ |
| O14920 | S672 | ELM | IKBKB IKKB | KELWNLLKIACSKVRGPVsGsPDsMNAsRLsQPGQLMsQPs |
| O14920 | S675 | ELM | IKBKB IKKB | WNLLKIACSKVRGPVsGsPDsMNAsRLsQPGQLMsQPstAs |
| O14920 | S682 | ELM | IKBKB IKKB | CSKVRGPVsGsPDsMNAsRLsQPGQLMsQPstAsNsLPEPA |
| O14920 | S689 | ELM | IKBKB IKKB | VsGsPDsMNAsRLsQPGQLMsQPstAsNsLPEPAKKsEELV |
| O14920 | S692 | ELM | IKBKB IKKB | sPDsMNAsRLsQPGQLMsQPstAsNsLPEPAKKsEELVAEA |
| O14920 | S695 | ELM | IKBKB IKKB | sMNAsRLsQPGQLMsQPstAsNsLPEPAKKsEELVAEAHNL |
| O14920 | S697 | ELM | IKBKB IKKB | NAsRLsQPGQLMsQPstAsNsLPEPAKKsEELVAEAHNLCT |
| O14920 | S705 | ELM | IKBKB IKKB | GQLMsQPstAsNsLPEPAKKsEELVAEAHNLCTLLENAIQD |
| O14920 | S733 | ELM | IKBKB IKKB | HNLCTLLENAIQDTVREQDQsFTALDWsWLQTEEEEHsCLE |
| O14920 | S740 | ELM | IKBKB IKKB | ENAIQDTVREQDQsFTALDWsWLQTEEEEHsCLEQAs____ |
| O14920 | S750 | ELM | IKBKB IKKB | QDQsFTALDWsWLQTEEEEHsCLEQAs______________ |
| O14965 | T288 | GPS6 | AURKA AIK AIRK1 ARK1 AURA AYK1 BTAK IAK1 STK15 STK6 | GELKIADFGWsVHAPssRRttLCGTLDYLPPEMIEGRMHDE |
| O14974 | S903 | Sugiyama | PPP1R12A MBS MYPT1 | QtDsIsRyETssTsAGDRyDsLLGRsGsysYLEERKPYSSR |
| O14974 | S912 | Sugiyama | PPP1R12A MBS MYPT1 | TssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDSTDF |
| O15111 | S123 | Sugiyama | CHUK IKKA TCF16 | LRKLLNKPENCCGLKESQILsLLsDIGSGIRYLHENKIIHR |
| O15111 | S126 | Sugiyama | CHUK IKKA TCF16 | LLNKPENCCGLKESQILsLLsDIGSGIRYLHENKIIHRDLK |
| O15111 | S249 | Sugiyama | CHUK IKKA TCF16 | TWHEKIKKKDPKCIFACEEMsGEVRFSSHLPQPNSLCSLVV |
| O15111 | S351 | Sugiyama | CHUK IKKA TCF16 | DESLHSLQSRIEREtGINTGsQELLsETGIsLDPRKPAsQC |
| O15111 | S356 | Sugiyama | CHUK IKKA TCF16 | SLQSRIEREtGINTGsQELLsETGIsLDPRKPAsQCVLDGV |
| O15111 | S361 | Sugiyama | CHUK IKKA TCF16 | IEREtGINTGsQELLsETGIsLDPRKPAsQCVLDGVRGCDs |
| O15111 | S369 | Sugiyama | CHUK IKKA TCF16 | TGsQELLsETGIsLDPRKPAsQCVLDGVRGCDsYMVYLFDK |
| O15111 | S381 | Sugiyama | CHUK IKKA TCF16 | sLDPRKPAsQCVLDGVRGCDsYMVYLFDKSKtVyEGPFAsR |
| O15111 | S400 | Sugiyama | CHUK IKKA TCF16 | DsYMVYLFDKSKtVyEGPFAsRsLsDCVNYIVQDsKIQLPI |
| O15111 | S402 | Sugiyama | CHUK IKKA TCF16 | YMVYLFDKSKtVyEGPFAsRsLsDCVNYIVQDsKIQLPIIQ |
| O15111 | S404 | Sugiyama | CHUK IKKA TCF16 | VYLFDKSKtVyEGPFAsRsLsDCVNYIVQDsKIQLPIIQLR |
| O15111 | S414 | Sugiyama | CHUK IKKA TCF16 | yEGPFAsRsLsDCVNYIVQDsKIQLPIIQLRKVWAEAVHYV |
| O15111 | S559 | Sugiyama | CHUK IKKA TCF16 | AEIMELQKSPYGRRQGDLMEsLEQRAIDLYKQLKHRPSDHs |
| O15111 | S579 | Sugiyama | CHUK IKKA TCF16 | sLEQRAIDLYKQLKHRPSDHsYSDStEMVKIIVHtVQsQDR |
| O15111 | S596 | Sugiyama | CHUK IKKA TCF16 | SDHsYSDStEMVKIIVHtVQsQDRVLKELFGHLSKLLGCKQ |
| O15111 | T23 | Sugiyama | CHUK IKKA TCF16 | RPPGLRPGAGGPWEMRERLGtGGFGNVCLYQHRELDLKIAI |
| O15111 | T294 | Sugiyama | CHUK IKKA TCF16 | NWLQLMLNWDPQQRGGPVDLtLKQPRCFVLMDHILNLKIVH |
| O15111 | T345 | Sugiyama | CHUK IKKA TCF16 | SFLLPPDESLHSLQSRIEREtGINTGsQELLsETGIsLDPR |
| O15111 | T392 | Sugiyama | CHUK IKKA TCF16 | VLDGVRGCDsYMVYLFDKSKtVyEGPFAsRsLsDCVNYIVQ |
| O15111 | T584 | Sugiyama | CHUK IKKA TCF16 | AIDLYKQLKHRPSDHsYSDStEMVKIIVHtVQsQDRVLKEL |
| O15111 | T593 | Sugiyama | CHUK IKKA TCF16 | HRPSDHsYSDStEMVKIIVHtVQsQDRVLKELFGHLSKLLG |
| O15111 | Y394 | Sugiyama | CHUK IKKA TCF16 | DGVRGCDsYMVYLFDKSKtVyEGPFAsRsLsDCVNYIVQDs |
| O43524 | S644 | SIGNOR|EPSD|PSP | FOXO3 FKHRL1 FOXO3A | MEsIIRSELMDADGLDFNFDsLISTQNVVGLNVGNFTGAKQ |
| O43715 | S32 | Sugiyama | TRIAP1 15E1.1 HSPC132 | KREYDQCFNRWFAEKFLKGDssGDPCTDLFKRYQQCVQKAI |
| O43823 | S323 | Sugiyama | AKAP8 AKAP95 | RKRKQFQLyEEPDtKLARVDsEGDFsENDDAAGDFRsGDEE |
| O43852 | S261 | Sugiyama | CALU | RDKNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNK |
| O43852 | S277 | Sugiyama | CALU | WILPsDyDHAEAEARHLVyEsDQNKDGKLTKEEIVDKyDLF |
| O43852 | S44 | Sugiyama | CALU | KKDRVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQL |
| O43852 | T89 | Sugiyama | CALU | sKERLGKIVSKIDGDKDGFVtVDELKDWIKFAQKRWIyEDV |
| O60220 | S57 | Sugiyama | TIMM8A DDP DDP1 TIM8A | HQMTELCWEKCMDKPGPKLDsRAEACFVNCVERFIDTSQFI |
| O60220 | S94 | Sugiyama | TIMM8A DDP DDP1 TIM8A | SQFILNRLEQTQKSKPVFSEsLsD_________________ |
| O60716 | S230 | Sugiyama | CTNND1 KIAA0384 | PDGysRHyEDGyPGGsDNyGsLsRVtRIEERyRPsMEGyRA |
| O60749 | S265 | Sugiyama | SNX2 TRG9 | RTVKHPTLLQDPDLRQFLEssELPRAVNTQALsGAGILRMV |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O60841 | S214 | Sugiyama | EIF5B IF2 KIAA0741 | LQsRKGQKKNQKNKPGPNIEsGNEDDDAsFKIKTVAQKKAE |
| O60841 | S66 | Sugiyama | EIF5B IF2 KIAA0741 | KEKKKQDFDEDDILKELEELsLEAQGIKADREtVAVKPTEN |
| O75347 | S103 | Sugiyama | TBCA | ENEKDLEEAEEyKEARLVLDsVKLEA_______________ |
| O75533 | T316 | Sugiyama | SF3B1 SAP155 | tPKtERDtPGHGsGWAEtPRtDRGGDsIGEtPtPGAsKRKs |
| O75683 | S13 | Sugiyama | SURF6 SURF-6 | ________MASLLAKDAyLQsLAKKICSHsAPEQQARTRAG |
| O75821 | S189 | Sugiyama | EIF3G EIF3S4 | CPYKDtLGPMQKELAEQLGLstGEKEKLPGELEPVQAtQNK |
| O75925 | S90 | iPTMNet | PIAS1 DDXBP1 | MTPADLSIPNVHSSPMPATLsPSTIPQLTYDGHPASSPLLP |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| O95757 | S599 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | sIDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERND |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00558 | S415 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GGGAsLELLEGKVLPGVDALsNI__________________ |
| P01106 | S82 | PSP | MYC BHLHE39 | EDIWKKFELLPtPPLsPsRRsGLCsPSyVAVTPFsLRGDND |
| P01106 | S86 | PSP | MYC BHLHE39 | KKFELLPtPPLsPsRRsGLCsPSyVAVTPFsLRGDNDGGGG |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P02786 | S137 | Sugiyama | TFRC | PAARRLyWDDLKRKLsEKLDstDFTGtIKLLNENsyVPREA |
| P03372 | S118 | EPSD|PSP | ESR1 ESR NR3A1 | PPLNsVsPsPLMLLHPPPQLsPFLQPHGQQVPYYLENEPSG |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04083 | S182 | Sugiyama | ANXA1 ANX1 LPC1 | RDLAKDItsDtsGDFRNALLsLAKGDRsEDFGVNEDLADsD |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | S312 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | sstFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMA |
| P04406 | S321 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE______ |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04406 | Y314 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | tFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsK |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04792 | S83 | Sugiyama | HSPB1 HSP27 HSP28 | IEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVNH |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S29 | Sugiyama | RPLP2 D11S2243E RPP2 | LAALGGNssPsAKDIKKILDsVGIEADDDRLNKVIsELNGK |
| P05388 | S307 | Sugiyama | RPLP0 | AAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD__________ |
| P05455 | S325 | Sugiyama | SSB | VLEGEVEKEALKKIIEDQQEsLNKWKSKGRRFKGKGKGNKA |
| P05783 | S93 | Sugiyama | KRT18 CYK18 PIG46 | GMGGIQNEKETMQsLNDRLAsyLDRVRSLETENRRLESKIR |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P05787 | S291 | Sugiyama | KRT8 CYK8 | ANRsRAEAEsMyQIKyEELQsLAGKHGDDLRRTKTEISEMN |
| P06733 | S27 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | HAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEAL |
| P06733 | S291 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IsPDQLADLyKsFIKDyPVVsIEDPFDQDDWGAWQKFtAsA |
| P06733 | S349 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | AKAVNEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMV |
| P06733 | S353 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMVsHRs |
| P06733 | T19 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | __MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGA |
| P06733 | Y287 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | PsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDDWGAWQKF |
| P06748 | S137 | Sugiyama | NPM1 NPM | VAVEEDAEsEDEEEEDVKLLsIsGKRsAPGGGsKVPQKKVK |
| P06748 | S43 | Sugiyama | NPM1 NPM | LKADKDyHFKVDNDENEHQLsLRTVsLGAGAKDELHIVEAE |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | S320 | Sugiyama | LDHB | GLtsVINQKLKDDEVAQLKKsADtLWDIQKDLKDL______ |
| P07237 | S427 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | WDKLGEtyKDHENIVIAKMDstANEVEAVKVHsFPtLKFFP |
| P07237 | S439 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | NIVIAKMDstANEVEAVKVHsFPtLKFFPAsADRtVIDyNG |
| P07237 | S88 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GKLKAEGSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNG |
| P07237 | T442 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | IAKMDstANEVEAVKVHsFPtLKFFPAsADRtVIDyNGERt |
| P07237 | T85 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | KAAGKLKAEGSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFF |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07711 | T332 | Sugiyama | CTSL CTSL1 | VKMAKDRRNHCGIAsAAsyPtV___________________ |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S50 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MSLIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKL |
| P07900 | S505 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KENQKHIyyItGETKDQVANsAFVERLRKHGLEVIyMIEPI |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P08195 | S598 | Sugiyama | SLC3A2 MDU1 | LQASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEP |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | S497 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEtQKsIyyItGEsKEQVANsAFVERVRKRGFEVVyMtEPI |
| P08238 | S535 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EPIDEyCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKKMEE |
| P08670 | S325 | Sugiyama | VIM | NNDALRQAKQESTEYRRQVQsLtCEVDALKGtNEsLERQMR |
| P08670 | S430 | Sugiyama | VIM | RIsLPLPNFssLNLREtNLDsLPLVDtHsKRTLLIKtVEtR |
| P08708 | S89 | Sugiyama | RPS17 RPS17L | ISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKEMLKLL |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P09234 | S48 | Sugiyama | SNRPC | RKHKENVKDYYQKWMEEQAQsLIDKTTAAFQQGKIPPTPFS |
| P09382 | S63 | Sugiyama | LGALS1 | CLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVFPFQPG |
| P0C0S5 | S99 | Sugiyama | H2AZ1 H2AFZ H2AZ | VKRITPRHLQLAIRGDEELDsLIKATIAGGGVIPHIHKSLI |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0DJD0 | S964 | Sugiyama | RGPD1 RANBP2L6 RGP1 | GVIFGQTSSTFTFADVAKstsGEGFQFGKKDPNFKGFSGAG |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P0DPH7 | S54 | Sugiyama | TUBA3C TUBA2 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| P0DPH7 | T41 | Sugiyama | TUBA3C TUBA2 | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10809 | S453 | Sugiyama | HSPD1 HSP60 | EEGIVLGGGCALLRCIPALDsLtPANEDQKIGIEIIKRTLK |
| P10809 | S488 | Sugiyama | HSPD1 HSP60 | IKRTLKIPAMtIAKNAGVEGsLIVEKIMQSSsEVGYDAMAG |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | S544 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KYKAEDEKQRDKVssKNsLEsyAFNMKATVEDEKLQGKIND |
| P11142 | T45 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtN |
| P11586 | T128 | Sugiyama | MTHFD1 MTHFC MTHFD | SINTEEVINAIAPEKDVDGLtsINAGKLARGDLNDCFIPCt |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P12277 | S164 | Sugiyama | CKB CKBB | PHCsRGERRAIEKLAVEALssLDGDLAGRyyALKsMtEAEQ |
| P13073 | S72 | Sugiyama | COX4I1 COX4 | VKHLSASQKALKEKEKASWssLsMDEKVELYRIKFKEsFAE |
| P13489 | S290 | Sugiyama | RNH1 PRI RNH | AKGCGDLCRVLRAKESLKELsLAGNELGDEGARLLCETLLE |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13798 | S8 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | _____________MERQVLLsEPEEAAALyRGLSRQPALsA |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14618 | T195 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | yVDDGLISLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAA |
| P14618 | T50 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | MCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMIKsGMN |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P14625 | S523 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | RtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMAG |
| P14649 | S87 | Sugiyama | MYL6B MLC1SA | EEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVLK |
| P15311 | S536 | Sugiyama | EZR VIL2 | KRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHNE |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15531 | S120 | Sugiyama | NME1 NDPKA NM23 | KPGtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELV |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P15880 | S206 | Sugiyama | RPS2 RPS4 | GRCGsVLVRLIPAPRGtGIVsAPVPKKLLMMAGIDDCytsA |
| P16070 | S71 | Sugiyama | CD44 LHR MDU2 MDU3 MIC4 | DLCKAFNSTLPTMAQMEKALsIGFEtCRyGFIEGHVVIPRI |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17066 | T47 | Sugiyama | HSPA6 HSP70B' | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P17544 | S44 | Sugiyama | ATF7 ATFA | LAVHKHKHEMTLKFGPARtDsVIIADQtPtPtRFLKNCEEV |
| P17987 | S551 | Sugiyama | TCP1 CCT1 CCTA | IKLHPESKDDKHGsyEDAVHsGALND_______________ |
| P18615 | S113 | Sugiyama | NELFE RD RDBP | EGKLKDPEKGPVPTFQPFQRsIsADDDLQEsSRRPQRKsLy |
| P18615 | S135 | Sugiyama | NELFE RD RDBP | sADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEAEG |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18669 | S152 | Sugiyama | PGAM1 PGAMA CDABP0006 | FysNIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIV |
| P18669 | S155 | Sugiyama | PGAM1 PGAMA CDABP0006 | NIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQI |
| P18754 | S90 | Sugiyama | RCC1 CHC1 | VQAEAGGMHTVCLSKsGQVysFGCNDEGALGRDtsVEGSEM |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19338 | S619 | Sugiyama | NCL | RIVTDRETGssKGFGFVDFNsEEDAKAAKEAMEDGEIDGNK |
| P19838 | S923 | SIGNOR|ELM|EPSD|PSP | NFKB1 | sLPLsPAstRQQIDELRDSDsVCDsGVEtsFRKLsFtEsLt |
| P19838 | S927 | GPS6|SIGNOR|ELM|EPSD|PSP | NFKB1 | sPAstRQQIDELRDSDsVCDsGVEtsFRKLsFtEsLtSGAS |
| P19838 | S932 | SIGNOR|EPSD|PSP | NFKB1 | RQQIDELRDSDsVCDsGVEtsFRKLsFtEsLtSGASLLTLN |
| P19838 | T931 | SIGNOR | NFKB1 | tRQQIDELRDSDsVCDsGVEtsFRKLsFtEsLtSGASLLTL |
| P20618 | S151 | Sugiyama | PSMB1 PSC5 | PYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASA |
| P20749 | S122 | SIGNOR | BCL3 BCL4 D19S37 | PLVNLPTPLYPMMCPMEHPLsADIAMATRADEDGDTPLHIA |
| P20749 | S454 | SIGNOR|EPSD|PSP | BCL3 BCL4 D19S37 | FAGVLRGPGRPVPPSPAPGGs____________________ |
| P22692 | S255 | Sugiyama | IGFBP4 IBP4 | VKLPGGLEPKGELDCHQLADsFRE_________________ |
| P23396 | S35 | Sugiyama | RPS3 OK/SW-cl.26 | GIFKAELNEFLtRELAEDGysGVEVRVtPTRTEIIILATRT |
| P23588 | S122 | Sugiyama | EIF4B | NLPyDVTEESIKEFFRGLNIsAVRLPREPsNPERLKGFGyA |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P24385 | T286 | SIGNOR|ELM|EPSD|PSP | CCND1 BCL1 PRAD1 | MDPKAAEEEEEEEEEVDLACtPtDVRDVDI___________ |
| P24752 | S218 | Sugiyama | ACAT1 ACAT MAT | ENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPV |
| P25054 | S1389 | Sugiyama | APC DP2.5 | PKsPPEHYVQETPLMFsRCTsVSsLDSFESRSIASSVQSEP |
| P25705 | S53 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | ARNFHASNTHLQKtGtAEMssILEERILGADtsVDLEETGR |
| P25705 | S76 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | EERILGADtsVDLEETGRVLsIGDGIARVHGLRNVQAEEMV |
| P25963 | S32 | SIGNOR|ELM|EPSD|PSP | NFKBIA IKBA MAD3 NFKBI | AMEGPRDGLKKERLLDDRHDsGLDsMKDEEyEQMVKELQEI |
| P25963 | S36 | SIGNOR|ELM|EPSD|PSP | NFKBIA IKBA MAD3 NFKBI | PRDGLKKERLLDDRHDsGLDsMKDEEyEQMVKELQEIRLEP |
| P26038 | S527 | Sugiyama | MSN | ERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHAE |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26373 | S109 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | KVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLILFPR |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T107 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | HKKVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLILF |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27695 | S129 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | QELPGLSHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGDE |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P27824 | S554 | Sugiyama | CANX | EKDKGDEEEEGEEKLEEKQKsDAEEDGGtVsQEEEDRKPKA |
| P28066 | S180 | Sugiyama | PSMA5 | GtFVQCDARAIGsAsEGAQssLQEVyHKSMTLKEAIKSSLI |
| P28340 | S1064 | Sugiyama | POLD1 POLD | LNALEERFSRLWTQCQRCQGsLHEDVICTSRDCPIFyMRKK |
| P29084 | S211 | Sugiyama | GTF2E2 TF2E2 | FVNRPDKKKILFFNDKSCQFsVDEEFQKLWRSVTVDsMDEE |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P29692 | S60 | Sugiyama | EEF1D EF1D | ENGAsVILRDIARARENIQKsLAGssGPGAssGtsGDHGEL |
| P29692 | S86 | Sugiyama | EEF1D EF1D | GPGAssGtsGDHGELVVRIAsLEVENQsLRGVVQELQQAIs |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30050 | S157 | Sugiyama | RPL12 | QsVGCNVDGRHPHDIIDDINsGAVECPAs____________ |
| P30086 | S139 | Sugiyama | PEBP1 PBP PEBP | RyVWLVyEQDRPLKCDEPILsNRsGDHRGKFKVAsFRKKyE |
| P30086 | S52 | Sugiyama | PEBP1 PBP PEBP | AAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPD |
| P30086 | S54 | Sugiyama | PEBP1 PBP PEBP | VDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPDAP |
| P30086 | S60 | Sugiyama | PEBP1 PBP PEBP | VLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPK |
| P30086 | T65 | Sugiyama | PEBP1 PBP PEBP | QVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREWH |
| P30533 | S137 | Sugiyama | LRPAP1 A2MRAP | VILAKYGLDGKKDARQVtsNsLsGtQEDGLDDPRLEKLWHK |
| P30626 | S111 | Sugiyama | SRI | GFNEFKELWAVLNGWRQHFIsFDTDRSGTVDPQELQKALtt |
| P31943 | S269 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | YNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQsttGH |
| P31943 | S272 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | GYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQsttGHCVH |
| P31943 | T286 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yCFsGMsDHRyGDGGstFQsttGHCVHMRGLPYRAtENDIy |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P31948 | S42 | Sugiyama | STIP1 | DALQCysEAIKLDPHNHVLysNRsAAyAKKGDYQKAyEDGC |
| P31948 | S45 | Sugiyama | STIP1 | QCysEAIKLDPHNHVLysNRsAAyAKKGDYQKAyEDGCKtV |
| P32969 | S182 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | QQATTVKNKDIRKFLDGIyVsEKGtVQQADE__________ |
| P33240 | S336 | Sugiyama | CSTF2 | PtPRGLLGDAPNDPRGGtLLsVtGEVEPRGYLGPPHQGPPM |
| P33316 | S164 | Sugiyama | DUT | YTIPPMEKAVVKTDIQIALPsGCyGRVAPRSGLAAKHFIDV |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34931 | T47 | Sugiyama | HSPA1L | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQN |
| P35222 | S33 | EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | AMEPDRKAAVsHWQQQsyLDsGIHsGATtTAPsLsGKGNPE |
| P35222 | S37 | EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | DRKAAVsHWQQQsyLDsGIHsGATtTAPsLsGKGNPEEEDV |
| P35222 | S45 | EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | WQQQsyLDsGIHsGATtTAPsLsGKGNPEEEDVDTsQVLyE |
| P35222 | T41 | EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | AVsHWQQQsyLDsGIHsGATtTAPsLsGKGNPEEEDVDTsQ |
| P35251 | S253 | Sugiyama | RFC1 RFC140 | DEEPKTKKARKDTEAGETFSsVQANLSKAEKHKYPHKVKTA |
| P35568 | S268 | ELM | IRS1 | NMHETILEAMRAMSDEFRPRsKsQsssNCSNPISVPLRRHH |
| P35568 | S270 | ELM | IRS1 | HETILEAMRAMSDEFRPRsKsQsssNCSNPISVPLRRHHLN |
| P35568 | S272 | ELM | IRS1 | TILEAMRAMSDEFRPRsKsQsssNCSNPISVPLRRHHLNNP |
| P35568 | S274 | ELM | IRS1 | LEAMRAMSDEFRPRsKsQsssNCSNPISVPLRRHHLNNPPP |
| P35568 | S307 | ELM | IRS1 | HHLNNPPPSQVGLTRRsRtEsItAtsPAsMVGGKPGsFRVR |
| P35568 | S312 | ELM | IRS1 | PPPSQVGLTRRsRtEsItAtsPAsMVGGKPGsFRVRAssDG |
| P35568 | S341 | ELM | IRS1 | PGsFRVRAssDGEGtMsRPAsVDGsPVsPstNRTHAHRHRG |
| P35568 | S345 | ELM | IRS1 | RVRAssDGEGtMsRPAsVDGsPVsPstNRTHAHRHRGsARL |
| P35568 | S527 | ELM | IRS1 | AGDEAASAADLDNRFRKRtHsAGtsPTITHQKTPSQSSVAs |
| P35568 | S531 | ELM | IRS1 | AASAADLDNRFRKRtHsAGtsPTITHQKTPSQSSVAsIEEy |
| P35579 | S1154 | Sugiyama | MYH9 | KRDLGEELEALKtELEDtLDstAAQQELRSKREQEVNILKK |
| P35613 | S277 | Sugiyama | BSG UNQ6505/PRO21383 | KITDSEDKALMNGSESRFFVsssQGRSELHIENLNMEADPG |
| P35637 | S340 | Sugiyama | FUS TLS | PMINLyTDRETGKLKGEAtVsFDDPPsAKAAIDWFDGKEFs |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P35998 | S89 | Sugiyama | PSMC2 MSS1 | DTGLAPPALWDLAADKQTLQsEQPLQVARCTKIINADSEDP |
| P36578 | S365 | Sugiyama | RPL4 RPL1 | RNHKLRVDKAAAAAAALQAKsDEKAAVAGKKPVVGKKGKKA |
| P36578 | S87 | Sugiyama | RPL4 RPL1 | WGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAPTKT |
| P36578 | T84 | Sugiyama | RPL4 RPL1 | AEsWGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAP |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P38646 | S212 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | tVPAyFNDsQRQAtKDAGQIsGLNVLRVINEPTAAALAyGL |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P42166 | S167 | Sugiyama | TMPO LAP2 | LKLREQGtEsRsstPLPtIsssAENtRQNGsNDsDRYsDNE |
| P42167 | S167 | Sugiyama | TMPO LAP2 | LKLREQGTESRsstPLPTISsSAENTRQNGSNDSDRYSDNE |
| P42345 | S1415 | SIGNOR|EPSD|PSP | MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 | KALHYKELEFQKGPTPAILEsLIsINNKLQQPEAAAGVLEY |
| P42345 | S1418 | PSP | MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 | HYKELEFQKGPTPAILEsLIsINNKLQQPEAAAGVLEYAMK |
| P43034 | S152 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | IKVWDyEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSADM |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46776 | S83 | Sugiyama | RPL27A | LKRNQsFCPtVNLDKLWtLVsEQtRVNAAKNKtGAAPIIDV |
| P46776 | T80 | Sugiyama | RPL27A | HYHLKRNQsFCPtVNLDKLWtLVsEQtRVNAAKNKtGAAPI |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P47914 | S142 | Sugiyama | RPL29 | KAKAKAKAKDQTKAQAAAPAsVPAQAPKRtQAPtKAsE___ |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P48741 | T47 | Sugiyama | HSPA7 HSP70B | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P49792 | S1955 | Sugiyama | RANBP2 NUP358 | GVIFGQTSSTFTFADLAKstsGEGFQFGKKDPNFKGFSGAG |
| P49840 | Y279 | Sugiyama | GSK3A | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P49841 | Y216 | Sugiyama | GSK3B | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P50990 | S23 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | LHVPKAPGFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTT |
| P51858 | S165 | Sugiyama | HDGF HMG1L2 | AKEKNEKGALKRRAGDLLEDsPKRPKEAENPEGEEKEAAtL |
| P52597 | S285 | Sugiyama | HNRNPF HNRPF | syCLsGMyDHRYGDsEFtVQsTTGHCVHMRGLPYKAtENDI |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54652 | T46 | Sugiyama | HSPA2 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTN |
| P55060 | S342 | Sugiyama | CSE1L CAS XPO2 | ASVCERPHYKNLFEDQNtLtsICEKVIVPNMEFRAADEEAF |
| P55795 | S269 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQstTGH |
| P55795 | S272 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | GYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQstTGHCVH |
| P55795 | S285 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | NyCFsGMsDHRyGDGGssFQstTGHCVHMRGLPYRATENDI |
| P55795 | T286 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | yCFsGMsDHRyGDGGssFQstTGHCVHMRGLPYRATENDIY |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60660 | S30 | Sugiyama | MYL6 | AEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVLK |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P61024 | S9 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | ____________MSHKQIyysDKyDDEEFEyRHVMLPKDIA |
| P61247 | S192 | Sugiyama | RPS3A FTE1 MFTL | MTREVQTNDLKEVVNKLIPDsIGKDIEKACQsIyPLHDVFV |
| P61247 | S263 | Sugiyama | RPS3A FTE1 MFTL | GDEtGAKVERADGyEPPVQEsV___________________ |
| P61254 | S9 | Sugiyama | RPL26 | ____________MKFNPFVtsDRsKNRKRHFNAPsHIRRKI |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61604 | S21 | Sugiyama | HSPE1 | MAGQAFRKFLPLFDRVLVERsAAETVTKGGIMLPEKSQGKV |
| P61604 | S64 | Sugiyama | HSPE1 | AtVVAVGsGsKGKGGEIQPVsVKVGDKVLLPEyGGtKVVLD |
| P61978 | S401 | Sugiyama | HNRNPK HNRPK | GDLGGPIIttQVtIPKDLAGsIIGKGGQRIKQIRHEsGAsI |
| P61978 | S420 | Sugiyama | HNRNPK HNRPK | GsIIGKGGQRIKQIRHEsGAsIKIDEPLEGsEDRIITItGt |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62263 | S137 | Sugiyama | RPS14 PRO2640 | RALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL______ |
| P62424 | T84 | Sugiyama | RPL7A SURF-3 SURF3 | QRQRAILyKRLKVPPAINQFtQALDRQTAtQLLKLAHKYRP |
| P62633 | S121 | Sugiyama | CNBP RNF163 ZNF9 | CGKPGHLARDCDHADEQKCysCGEFGHIQKDCTKVKCYRCG |
| P62633 | Y120 | Sugiyama | CNBP RNF163 ZNF9 | NCGKPGHLARDCDHADEQKCysCGEFGHIQKDCTKVKCYRC |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62857 | S39 | Sugiyama | RPS28 | GRtGsQGQCtQVRVEFMDDtsRsIIRNVKGPVREGDVLtLL |
| P62857 | S41 | Sugiyama | RPS28 | tGsQGQCtQVRVEFMDDtsRsIIRNVKGPVREGDVLtLLEs |
| P62899 | T119 | Sugiyama | RPL31 | PNKLytLVtyVPVttFKNLQtVNVDEN______________ |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62917 | S138 | Sugiyama | RPL8 | EKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVI |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P62979 | S134 | Sugiyama | RPS27A UBA80 UBCEP1 | IsRLRRECPsDECGAGVFMAsHFDRHyCGKCCLtyCFNKPE |
| P62979 | T147 | Sugiyama | RPS27A UBA80 UBCEP1 | GAGVFMAsHFDRHyCGKCCLtyCFNKPEDK___________ |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63167 | S21 | Sugiyama | DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1 | MCDRKAVIKNADMsEEMQQDsVECAtQALEKYNIEKDIAAH |
| P63220 | S31 | Sugiyama | RPS21 | LYVPRKCSASNRIIGAKDHAsIQMNVAEVDKVTGRFNGQFK |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P67809 | Y99 | Sugiyama | YBX1 NSEP1 YB1 | DtKEDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P68363 | S54 | Sugiyama | TUBA1B | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| P68363 | T41 | Sugiyama | TUBA1B | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | Y83 | Sugiyama | TUBA1B | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P83731 | S7 | Sugiyama | RPL24 | ______________MKVELCsFsGyKIYPGHGRRYARTDGK |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| Q00613 | S375 | Sugiyama | HSF1 HSTF1 | TDtEGRPPsPPPtstPEKCLsVACLDKNELSDHLDAMDSNL |
| Q00653 | S108 | EPSD|PSP | NFKB2 LYT10 | PAKIEVDLVTHsDPPRAHAHsLVGKQCsELGICAVsVGPKD |
| Q00653 | S115 | EPSD|PSP | NFKB2 LYT10 | LVTHsDPPRAHAHsLVGKQCsELGICAVsVGPKDMTAQFNN |
| Q00653 | S123 | EPSD|PSP | NFKB2 LYT10 | RAHAHsLVGKQCsELGICAVsVGPKDMTAQFNNLGVLHVTK |
| Q00653 | S866 | SIGNOR|PSP | NFKB2 LYT10 | LLRGPETRDKLPstAEVKEDsAyGsQsVEQEAEKLGPPPEP |
| Q00653 | S870 | SIGNOR|PSP | NFKB2 LYT10 | PETRDKLPstAEVKEDsAyGsQsVEQEAEKLGPPPEPPGGL |
| Q00653 | S872 | ELM|EPSD|PSP | NFKB2 LYT10 | TRDKLPstAEVKEDsAyGsQsVEQEAEKLGPPPEPPGGLCH |
| Q00653 | S99 | EPSD|PSP | NFKB2 LYT10 | TVKICNYEGPAKIEVDLVTHsDPPRAHAHsLVGKQCsELGI |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01105 | S166 | Sugiyama | SET | yFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQT |
| Q01105 | S168 | Sugiyama | SET | ENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQN |
| Q01201 | S472 | EPSD|PSP | RELB | GPFLPPSALLPDPDFFSGTVsLPGLEPPGGPDLLDDGFAYD |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q04206 | S536 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RELA NFKB3 | APLGAPGLPNGLLsGDEDFSsIADMDFsALLSQISS_____ |
| Q04864 | S516 | GPS6 | REL | VNMMTTSsDSMGETDNPRLLsMNLENPsCNsVLDPRDLRQL |
| Q04864 | S526 | GPS6 | REL | MGETDNPRLLsMNLENPsCNsVLDPRDLRQLHQMSSSSMSA |
| Q04864 | S557 | EPSD|PSP | REL | HQMSSSSMSAGANSNTTVFVsQSDAFEGSDFSCADNSMINE |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q06323 | S55 | Sugiyama | PSME1 IFI5111 | KKIsELDAFLKEPALNEANLsNLKAPLDIPVPDPVKEKEKE |
| Q07021 | S210 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | EDEVGQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDS |
| Q07157 | S1063 | Sugiyama | TJP1 ZO1 | LPYVEKQAsRDLEQPtyRyEsssytDQFsRNYEHRLRYEDR |
| Q07955 | S182 | Sugiyama | SRSF1 ASF SF2 SF2P33 SFRS1 OK/SW-cl.3 | FVRKEDMTYAVRKLDNTKFRsHEGEtAyIRVKVDGPRsPsy |
| Q08209 | S498 | Sugiyama | PPP3CA CALNA CNA | RINERMPPRRDAMPsDANLNsINKALTSETNGTDSNGSNSS |
| Q12888 | S197 | Sugiyama | TP53BP1 | QsQDVEENTVPYEVDKEQLQsVttNsGytRLsDVDANtAIK |
| Q13136 | S666 | Sugiyama | PPFIA1 LIP1 | IQEEKENTEQRAEEIESRVGsGsLDNLGRFRSMssIPPYPA |
| Q13242 | S172 | Sugiyama | SRSF9 SFRS9 SRP30C | yLRKEDMEYALRKLDDTKFRsHEGEtsYIRVYPERstsYGY |
| Q13263 | S784 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | DVGRMFKQFNKLTEDKADVQsIIGLQRFFETRMNEAFGDTK |
| Q13283 | S250 | Sugiyama | G3BP1 G3BP | sssPAPADIAQtVQEDLRtFsWAsVtsKNLPPSGAVPVTGI |
| Q13283 | S253 | Sugiyama | G3BP1 G3BP | PAPADIAQtVQEDLRtFsWAsVtsKNLPPSGAVPVTGIPPH |
| Q13442 | S176 | Sugiyama | PDAP1 HASPP28 | KKEEERKAKDDATLsGKRMQsLsLNK_______________ |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13526 | S105 | Sugiyama | PIN1 | ALELINGyIQKIKSGEEDFEsLAsQFSDCSsAKARGDLGAF |
| Q13573 | S190 | Sugiyama | SNW1 SKIIP SKIP | KLAPAQyIRytPsQQGVAFNsGAKQRVIRMVEMQKDPMEPP |
| Q13601 | S284 | Sugiyama | KRR1 HRB2 | KEYtPFPPPQPESQIDKELAsGEyFLKANQKKRQKMEAIKA |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14152 | S988 | Sugiyama | EIF3A EIF3S10 KIAA0139 | PRRGPEEDRFsRRGADDDRPsWRNTDDDRPPRRIADEDRGN |
| Q14157 | S855 | Sugiyama | UBAP2L KIAA0144 NICE4 | ysIPFPtPttPLtGRDGsLAsNPysGDLtKFGRGDASSPAP |
| Q14192 | S238 | Sugiyama | FHL2 DRAL SLIM3 | AKKCAGCTNPISGLGGtKyIsFEERQWHNDCFNCKKCsLsL |
| Q14247 | S117 | Sugiyama | CTTN EMS1 | KsAVGHEyQSKLsKHCsQVDsVRGFGGKFGVQMDRVDQsAV |
| Q14247 | S282 | Sugiyama | CTTN EMS1 | QKDyKTGFGGKFGVQsERQDsAAVGFDyKEKLAKHEsQQDy |
| Q14320 | S292 | Sugiyama | FAM50A DXS9928E HXC26 XAP5 | ARGKsGPLFNFDVHDDVRLLsDATVEKDESHAGKVVLRSWY |
| Q14444 | S307 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | SEVESTEYVNRQFMAEtQFtsGEKEQVDEWTVETVEVVNSL |
| Q14498 | S337 | Sugiyama | RBM39 HCC1 RNPC2 | AGRPMKVGHVTERtDAssAssFLDsDELERtGIDLGtTGRL |
| Q14568 | S50 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | MSLIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKL |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14677 | S166 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | REERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKWDE |
| Q14847 | S99 | Sugiyama | LASP1 MLN50 | ELQsQVRYKEEFEKNKGKGFsVVADtPELQRIKKTQDQIsN |
| Q14978 | S693 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | EKTKKKRGsYRGGsIsVQVNsIKFDsE______________ |
| Q14978 | S698 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | KRGsYRGGsIsVQVNsIKFDsE___________________ |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15056 | S110 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | DEVDsLKEALtyDGALLGDRsLRVDIAEGRKQDKGGFGFRK |
| Q15056 | S14 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | _______MADFDtyDDRAyssFGGGRGsRGsAGGHGsRSQK |
| Q15080 | S67 | Sugiyama | NCF4 SH3PXD4 | TKGGSKYLIYRRYRQFHALQsKLEERFGPDSKSSALACTLP |
| Q15653 | S19 | iPTMNet | NFKBIB IKBB TRIP9 | __MAGVACLGKAADADEWCDsGLGsLGPDAAAPGGPGLGAE |
| Q15653 | S23 | iPTMNet | NFKBIB IKBB TRIP9 | GVACLGKAADADEWCDsGLGsLGPDAAAPGGPGLGAELGPG |
| Q15717 | S304 | SIGNOR|EPSD|PSP | ELAVL1 HUR | CKGFGFVTMTNYEEAAMAIAsLNGYRLGDKILQVsFKTNKS |
| Q2TAL8 | S33 | Sugiyama | QRICH1 | EYIRVKARSVPQHRMKEFLDsLASKGPEALQEFQQTATTTM |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q53EL6 | S48 | Sugiyama | PDCD4 H731 | EENAGTEEIKNEINGNWIsAssINEARINAKAKRRLRKNss |
| Q53EL6 | S49 | Sugiyama | PDCD4 H731 | ENAGTEEIKNEINGNWIsAssINEARINAKAKRRLRKNssR |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF7 | S370 | Sugiyama | HSP90AB3P HSP90BC | KETQKSTYYITGESKEQVANsAFVERVRKQGFEVVYMTEPI |
| Q58FF7 | S408 | Sugiyama | HSP90AB3P HSP90BC | EPIDEYCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKKMEE |
| Q58FF8 | S308 | Sugiyama | HSP90AB2P HSP90BB | YMTEPIDGYQLKEFDGKsLVsVtKEGLELPEDGEEKKRMEE |
| Q5BKZ1 | S121 | Sugiyama | ZNF326 ZIRD | SRFGGSYGGRFESSYRNsLDsFGGRNQGGssWEAPysRSKL |
| Q5VT52 | S1180 | Sugiyama | RPRD2 KIAA0460 HSPC099 | TGFKTAPYKERAPQFQEsVGsFRsNsFNstFEHHLPPsPLE |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q676U5 | S278 | EPSD|PSP | ATG16L1 APG16L UNQ9393/PRO34307 | RAISRAATKRLsQPAGGLLDsITNIFGRRsVssFPVPQDNV |
| Q6FI81 | S305 | Sugiyama | CIAPIN1 CUA001 PRO0915 | CAsCPyLGMPAFKPGEKVLLsDsNLHDA_____________ |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6PEY2 | S54 | Sugiyama | TUBA3E | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q6PEY2 | T41 | Sugiyama | TUBA3E | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6UN15 | S496 | Sugiyama | FIP1L1 FIP1 RHE | DRERERTRERERERDHsPtPsVFNsDEERyRYREYAERGYE |
| Q6UN15 | S500 | Sugiyama | FIP1L1 FIP1 RHE | ERTRERERERDHsPtPsVFNsDEERyRYREYAERGYERHRA |
| Q6UXH1 | S295 | Sugiyama | CRELD2 UNQ185/PRO211 | KECISGYAREHGQCADVDECsLAEKtCVRKNENCYNTPGSY |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q6ZN18 | S206 | Sugiyama | AEBP2 | DEGYGTGGGGSSATSGGRRGsLEMssDGEPLSRMDSEDSIS |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q71U36 | S54 | Sugiyama | TUBA1A TUBA3 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q71U36 | T41 | Sugiyama | TUBA1A TUBA3 | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | Y83 | Sugiyama | TUBA1A TUBA3 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q71UI9 | S99 | Sugiyama | H2AZ2 H2AFV H2AV | VKRITPRHLQLAIRGDEELDsLIKATIAGGGVIPHIHKSLI |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7RTV0 | S53 | Sugiyama | PHF5A | CDSyVRPCTLVRICDECNyGsyQGRCVICGGPGVSDAyyCK |
| Q7Z2W4 | S364 | Sugiyama | ZC3HAV1 ZC3HDC2 PRO1677 | PGstyLASNsTsAPNWKsLtsWtNDQGARRKtVFsPtLPAA |
| Q7Z3J3 | S980 | Sugiyama | RGPD4 RGP4 | GVIFGQTSSTFTFADVAKstsGEGFQFGKKDPNFKGFSGAG |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86UE4 | S306 | Sugiyama | MTDH AEG1 LYRIC | WNEKSVKLssQIsAGEEKWNsVsPAsAGKRKtEPSAWsQDt |
| Q86V81 | T148 | Sugiyama | ALYREF ALY BEF THOC4 | EFGtLKKAAVHYDRsGRsLGtADVHFERKADALKAMKQYNG |
| Q86VP1 | S593 | SIGNOR|EPSD|PSP | TAX1BP1 T6BP PRO0105 | AENVKLELAEVQDNyKELKRsLENPAERKMEGQNSQsPQCF |
| Q86VP1 | S666 | SIGNOR|EPSD | TAX1BP1 T6BP PRO0105 | DGADGAFYPDEIQRPPVRVPsWGLEDNVVCSQPARNFsRPD |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8IWX8 | S904 | Sugiyama | CHERP DAN26 SCAF6 | KGVGVALDDPyENyRRNKsysFIARMKARDECK________ |
| Q8N3F0 | S58 | SIGNOR|EPSD|PSP | MTURN C7orf41 | GVSFYVLCPDNGCGDNFHVWsESEDCLPFLQLAQDYISSCG |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8NFH8 | S631 | Sugiyama | REPS2 POB1 | AIQTAIRKNKEANAVLARLNsELQQQLKEVHQERIALENQL |
| Q8NHW5 | S307 | Sugiyama | RPLP0P6 | AAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD__________ |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8WU90 | S351 | Sugiyama | ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 | DIDLSLYIPRDVDEtGItVAsLERFSTYTsDKDENKLsEAs |
| Q8WUD4 | S152 | Sugiyama | CCDC12 | QRAIAELIRERLKGQEDsLAsAVDAATEQKtCDsD______ |
| Q8WWI1 | S704 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | KKRLMVERLFQKIYGENGsKsMsDVsAEDVQNLRQLRYEEM |
| Q8WWI1 | S706 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | RLMVERLFQKIYGENGsKsMsDVsAEDVQNLRQLRYEEMQK |
| Q8WXX5 | S215 | Sugiyama | DNAJC9 | EEAKEAEMSRKELGLDEGVDsLKAAIQSRQKDRQKEMDNFL |
| Q92733 | S278 | Sugiyama | PRCC TPRC | KQItQEEDDsDEEVAPENFFsLPEKAEPPGVEPYPYPIPTV |
| Q92793 | S1382 | SIGNOR|EPSD|PSP | CREBBP CBP | VASSDKTVEVKPGMKSRFVDsGEMsESFPYRTKALFAFEEI |
| Q92793 | S1386 | SIGNOR|EPSD|PSP | CREBBP CBP | DKTVEVKPGMKSRFVDsGEMsESFPYRTKALFAFEEIDGVD |
| Q92804 | S289 | Sugiyama | TAF15 RBP56 TAF2N | PMINLYTDKDTGKPKGEAtVsFDDPPsAKAAIDWFDGKEFH |
| Q92890 | S294 | Sugiyama | UFD1 UFD1L | SRPLVKKVEEDEAGGRFVAFsGEGQsLRKKGRKP_______ |
| Q92905 | S201 | SIGNOR|PSP | COPS5 CSN5 JAB1 | VNLGAFRTYPKGYKPPDEGPsEyQtIPLNKIEDFGVHCKQY |
| Q92905 | T205 | SIGNOR|PSP | COPS5 CSN5 JAB1 | AFRTYPKGYKPPDEGPsEyQtIPLNKIEDFGVHCKQYYALE |
| Q92934 | S25 | SIGNOR | BAD BBC6 BCL2L8 | PEFEPSEQEDSSSAERGLGPsPAGDGPsGsGKHHRQAPGLL |
| Q92945 | S193 | Sugiyama | KHSRP FUBP2 | DSGCKVQIsPDsGGLPERsVsLtGAPEsVQKAKMMLDDIVS |
| Q96AE4 | S52 | Sugiyama | FUBP1 | KDALQRARQIAAKIGGDAGtsLNsNDyGyGGQKRPLEDGDQ |
| Q96AE4 | S55 | Sugiyama | FUBP1 | LQRARQIAAKIGGDAGtsLNsNDyGyGGQKRPLEDGDQPDA |
| Q96C01 | S135 | Sugiyama | FAM136A | VDDHMHLIPTMTKKMKEALLsIGK_________________ |
| Q96D71 | S767 | Sugiyama | REPS1 | AIQAsIRRNKETNTVLARLNsELQQQLKDVLEERISLEVQL |
| Q96HE7 | S143 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | EANNLIEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSD |
| Q99558 | S814 | PSP | MAP3K14 NIK | ILSCLSIDSLSLSDDSEKNPsKAsQSsRDTLSsGVHsWSSQ |
| Q99558 | S817 | PSP | MAP3K14 NIK | CLSIDSLSLSDDSEKNPsKAsQSsRDTLSsGVHsWSSQAEA |
| Q99558 | S820 | PSP | MAP3K14 NIK | IDSLSLSDDSEKNPsKAsQSsRDTLSsGVHsWSSQAEARSS |
| Q99558 | T559 | SIGNOR | MAP3K14 NIK | VCLQPDGLGKSLLTGDYIPGtETHMAPEVVLGRSCDAKVDV |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q99666 | S979 | Sugiyama | RGPD5 RANBP2L1 RGP5 RGP7 RGPD7; RGPD6 RANBP2L2 RGP6 | GVIFGQTSSTFTFADVAKstsGEGFQFGKKDLNFKGFSGAG |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BQE3 | S54 | Sugiyama | TUBA1C TUBA6 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q9BQE3 | T41 | Sugiyama | TUBA1C TUBA6 | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | Y83 | Sugiyama | TUBA1C TUBA6 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q9BR76 | S391 | Sugiyama | CORO1B | EAALEAEEWVSGRDADPILIsLREAYVPSKQRDLKISRRNV |
| Q9BTC0 | S352 | Sugiyama | DIDO1 C20orf158 DATF1 KIAA0333 | TADQQEAKWRPGDADGTDCTsIGtIEQKSSEDQGIKGRIEK |
| Q9BUZ4 | S426 | SIGNOR|EPSD|PSP | TRAF4 CART1 MLN62 RNF83 | ETFHPDPNWKNFQKPGtWRGsLDEsSLGFGYPKFISHQDIR |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BXH1 | S10 | EPSD|PSP | BBC3 PUMA | ___________MARARQEGSsPEPVEGLARDGPRPFPLGRL |
| Q9BY44 | S526 | Sugiyama | EIF2A CDA02 MSTP004 MSTP089 | sPDLAPtPAPQstPRNtVsQsIsGDPEIDKKIKNLKKKLKA |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9BZI7 | S166 | Sugiyama | UPF3B RENT3B UPF3X | KRDTKVGtIDDDPEyRKFLEsyAtDNEKMTstPEtLLEEIE |
| Q9C0C2 | S920 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | QDANEQGQDLGKRDHHGRyssQDADEQDWEFQKRDVsLGTy |
| Q9C0C7 | S1043 | SIGNOR|PSP | AMBRA1 DCAF3 KIAA1736 | GLAYGTNKGDLVICRPEALNsGVEYYWDQLNETVFTVHSNS |
| Q9GZT3 | S15 | Sugiyama | SLIRP C14orf156 DC23 DC50 PD04872 | ______MAASAARGAAALRRsINQPVAFVRRIPWTAASSQL |
| Q9H0L4 | S344 | Sugiyama | CSTF2T KIAA0689 | LPPRGLLGDAPNDPRGGtLLsVtGEVEPRGYLGPPHQGPPM |
| Q9H3Q1 | S312 | Sugiyama | CDC42EP4 BORG4 CEP4 | sPGsARSMGSHTTRDSSsLssCtsGILEERsPAFRGPDRAR |
| Q9H6F5 | S136 | Sugiyama | CCDC86 CYCLON | CQPKPSEEAPKCsQDQGVLAsELAQNKEELtPGAPQHQLPP |
| Q9NP61 | S370 | Sugiyama | ARFGAP3 ARFGAP1 | FTSSSSYFDEPVELRsssFssWDDssDSyWKKETSKDTETV |
| Q9NPA8 | S100 | Sugiyama | ENY2 DC6 | PDSVKKELLQRIRTFLAQHAsL___________________ |
| Q9NQC7 | S418 | SIGNOR | CYLD CYLD1 KIAA0849 HSPC057 | ssPPLQPPPVNSLTTENRFHsLPFsLtKMPNTNGsIGHsPL |
| Q9NQC7 | S422 | SIGNOR | CYLD CYLD1 KIAA0849 HSPC057 | LQPPPVNSLTTENRFHsLPFsLtKMPNTNGsIGHsPLsLsA |
| Q9NQC7 | S432 | SIGNOR | CYLD CYLD1 KIAA0849 HSPC057 | TENRFHsLPFsLtKMPNTNGsIGHsPLsLsAQsVMEELNTA |
| Q9NQC7 | S436 | SIGNOR | CYLD CYLD1 KIAA0849 HSPC057 | FHsLPFsLtKMPNTNGsIGHsPLsLsAQsVMEELNTAPVQE |
| Q9NQC7 | S439 | SIGNOR | CYLD CYLD1 KIAA0849 HSPC057 | LPFsLtKMPNTNGsIGHsPLsLsAQsVMEELNTAPVQESPP |
| Q9NQC7 | S441 | SIGNOR | CYLD CYLD1 KIAA0849 HSPC057 | FsLtKMPNTNGsIGHsPLsLsAQsVMEELNTAPVQESPPLA |
| Q9NQC7 | S444 | SIGNOR | CYLD CYLD1 KIAA0849 HSPC057 | tKMPNTNGsIGHsPLsLsAQsVMEELNTAPVQESPPLAMPP |
| Q9NRA8 | S353 | Sugiyama | EIF4ENIF1 | SASRFSRWFSNPsRsGsRsssLGstPHEELERLAGLEQAIL |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NVS9 | S55 | Sugiyama | PNPO | GPMRKsYRGDREAFEETHLTsLDPVKQFAAWFEEAVQCPDI |
| Q9NYF8 | S198 | Sugiyama | BCLAF1 BTF KIAA0164 | PLKsKsQEEPKDtFEHDPsEsIDEFNKssAtsGDIWPGLsA |
| Q9UBR2 | S78 | Sugiyama | CTSZ | SPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHAST |
| Q9UII2 | S39 | Sugiyama | ATP5IF1 ATPI ATPIF1 | TMQARGFGsDQSENVDRGAGsIREAGGAFGKREQAEEERyF |
| Q9UKS6 | S327 | Sugiyama | PACSIN3 | QRtIsRKEKGGRsPDEVtLtsIVPTRDGTAPPPQsPGsPGt |
| Q9UNX3 | S9 | Sugiyama | RPL26L1 RPL26P1 | ____________MKFNPFVtsDRsKNRKRHFNAPSHVRRKI |
| Q9UNZ2 | S176 | Sugiyama | NSFL1C UBXN2C | RLGAAPEEEsAyVAGEKRQHssQDVHVVLKLWKsGFsLDNG |
| Q9UNZ2 | S74 | Sugiyama | NSFL1C UBXN2C | SQATPssVsRGTAPSDNRVtsFRDLIHDQDEDEEEEEGQRF |
| Q9UPQ0 | S204 | Sugiyama | LIMCH1 KIAA1102 | DsERsDsLsPPRHGRDDsFDsLDsFGsRsRQtPsPDVVLRG |
| Q9UQ35 | S854 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sHSsssPHPKVKsGtPPRQGsItsPQANEQsVtPQRRsCFE |
| Q9UQ35 | S875 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ItsPQANEQsVtPQRRsCFEssPDPELKsRtPsRHsCsGss |
| Q9Y243 | S472 | Sugiyama | AKT3 PKBG | YDEDGMDCMDNERRPHFPQFsysAsGRE_____________ |
| Q9Y243 | S474 | Sugiyama | AKT3 PKBG | EDGMDCMDNERRPHFPQFsysAsGRE_______________ |
| Q9Y261 | S107 | SIGNOR|EPSD|PSP | FOXA2 HNF3B TCF3B | MAGMGGSAGAAGVAGMGPHLsPSLsPLGGQAAGAMGGLAPY |
| Q9Y261 | S111 | SIGNOR|EPSD|PSP | FOXA2 HNF3B TCF3B | GGSAGAAGVAGMGPHLsPSLsPLGGQAAGAMGGLAPYANMN |
| Q9Y266 | T283 | Sugiyama | NUDC | EINtKKINPENsKLsDLDsEtRsMVEKMMYDQRQKsMGLPt |
| Q9Y2B0 | S115 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | QIDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKF |
| Q9Y2B0 | S127 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | RVVGRNGEssELDLQGIRIDsDISGtLKFACEsIVEEyEDE |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2T7 | S137 | Sugiyama | YBX2 CSDA3 MSY2 | EDVFVHQtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEA |
| Q9Y3B8 | S203 | Sugiyama | REXO2 SFN SMFN CGI-114 | EYEFAPKKAAsHRALDDIsEsIKELQFyRNNIFKKKIDEKK |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
| Q9Y450 | S67 | Sugiyama | HBS1L HBS1 KIAA1038 | KPsVEPVEEyDyEDLKEssNsVsNHQLSGFDQARLYsCLDH |
| Q9Y4H2 | S304 | ELM | IRS2 | HETILEAMKALKELFEFRPRsKsQssGssATHPISVPGARR |
| Q9Y4H2 | S306 | ELM | IRS2 | TILEAMKALKELFEFRPRsKsQssGssATHPISVPGARRHH |
| Q9Y4H2 | S384 | ELM | IRS2 | AsEGDGGAAAGAAAAGARPVsVAGsPLsPGPVRAPLsRSHt |
| Q9Y4H2 | S388 | ELM | IRS2 | DGGAAAGAAAAGARPVsVAGsPLsPGPVRAPLsRSHtLsGG |
| Q9Y4H2 | S577 | ELM | IRS2 | RRVsGDAAQDLDRGLRKRtYsLtTPARQRPVPQPssAsLDE |
| Q9Y5L4 | S57 | Sugiyama | TIMM13 TIM13B TIMM13A TIMM13B | ELLQRMTDKCFRKCIGKPGGsLDNSEQKCIAMCMDRyMDAW |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y618 | S2407 | SIGNOR|PSP | NCOR2 CTG26 | SDHTLTSPGGGGKAKVSGRPsSRKAKsPAPGLASGDRPPsV |
| Q9Y620 | S64 | Sugiyama | RAD54B | FEGVAINNTFLPSQNDLRICsLNLPSEESTREINNRDNCSG |
| Q9Y6K9 | S376 | SIGNOR | IKBKG FIP3 NEMO | MRKRHVEVSQAPLPPAPAyLssPLALPsQRRsPPEEPPDFC |
| Q9Y6K9 | S43 | SIGNOR | IKBKG FIP3 NEMO | DQDVLGEEsPLGKPAMLHLPsEQGAPETLQRCLEENQELRD |
| Q9Y6K9 | S68 | SIGNOR | IKBKG FIP3 NEMO | PETLQRCLEENQELRDAIRQsNQILRERCEELLHFQAsQRE |
| Q9Y6K9 | S85 | SIGNOR | IKBKG FIP3 NEMO | IRQsNQILRERCEELLHFQAsQREEKEFLMCKFQEARKLVE |
| Q9Y6Q9 | S857 | SIGNOR|iPTMNet|EPSD|PSP | NCOA3 AIB1 BHLHE42 RAC3 TRAM1 | LGLKSSQSVQSIRPPYNRAVsLDsPVsVGssPPVKNISAFP |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.043243e-11 | 10.517 | 1 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.249020e-08 | 7.372 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 4.495452e-07 | 6.347 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.556197e-06 | 5.592 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.556197e-06 | 5.592 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.100211e-06 | 5.292 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 5.366594e-06 | 5.270 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.086783e-05 | 4.964 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.083024e-05 | 4.511 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.920856e-05 | 4.308 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.587315e-05 | 4.253 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 5.904956e-05 | 4.229 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 9.605653e-05 | 4.017 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.348987e-04 | 3.870 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.489400e-04 | 3.827 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.535451e-04 | 3.814 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.693994e-04 | 3.771 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.326776e-04 | 3.633 | 1 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.534329e-04 | 3.596 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.640991e-04 | 3.578 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.870226e-04 | 3.542 | 1 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.870226e-04 | 3.542 | 1 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.165666e-04 | 3.500 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 3.232816e-04 | 3.490 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.081565e-04 | 3.511 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.133689e-04 | 3.504 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 5.023806e-04 | 3.299 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 5.260756e-04 | 3.279 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 5.652298e-04 | 3.248 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 7.044648e-04 | 3.152 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 7.510950e-04 | 3.124 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 9.122474e-04 | 3.040 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.022386e-03 | 2.990 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 1.067114e-03 | 2.972 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.197834e-03 | 2.922 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.185085e-03 | 2.926 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.266752e-03 | 2.897 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.354893e-03 | 2.868 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.402335e-03 | 2.853 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.629555e-03 | 2.788 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.537578e-03 | 2.813 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.567089e-03 | 2.805 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.590155e-03 | 2.799 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.604996e-03 | 2.795 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.872191e-03 | 2.728 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.001769e-03 | 2.699 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 2.135104e-03 | 2.671 | 1 | 1 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.190491e-03 | 2.659 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.409630e-03 | 2.618 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.406426e-03 | 2.619 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.690338e-03 | 2.570 | 1 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.841350e-03 | 2.546 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.066789e-03 | 2.513 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 3.518541e-03 | 2.454 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.554227e-03 | 2.449 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.765951e-03 | 2.424 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 4.247745e-03 | 2.372 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 4.187811e-03 | 2.378 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.536704e-03 | 2.343 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.470764e-03 | 2.350 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 4.559561e-03 | 2.341 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 4.559561e-03 | 2.341 | 1 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.704970e-03 | 2.327 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.741041e-03 | 2.324 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.911938e-03 | 2.309 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 5.383321e-03 | 2.269 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 5.450691e-03 | 2.264 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 5.450691e-03 | 2.264 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 5.671245e-03 | 2.246 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 5.722498e-03 | 2.242 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.729672e-03 | 2.242 | 1 | 1 |
| Cellular Senescence | R-HSA-2559583 | 5.755425e-03 | 2.240 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 6.364549e-03 | 2.196 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 6.771455e-03 | 2.169 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 6.771455e-03 | 2.169 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 6.988342e-03 | 2.156 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 6.996726e-03 | 2.155 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 7.056138e-03 | 2.151 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 7.620241e-03 | 2.118 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 7.676168e-03 | 2.115 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 7.759053e-03 | 2.110 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 8.000358e-03 | 2.097 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 8.000358e-03 | 2.097 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 8.452329e-03 | 2.073 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 8.474025e-03 | 2.072 | 1 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 8.531454e-03 | 2.069 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.027412e-02 | 1.988 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.027412e-02 | 1.988 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.027412e-02 | 1.988 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.027412e-02 | 1.988 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.027412e-02 | 1.988 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.027412e-02 | 1.988 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.027412e-02 | 1.988 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.027412e-02 | 1.988 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.027412e-02 | 1.988 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.027412e-02 | 1.988 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.027412e-02 | 1.988 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 9.106427e-03 | 2.041 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 9.106427e-03 | 2.041 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 9.392439e-03 | 2.027 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.076750e-02 | 1.968 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.455683e-03 | 2.024 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 9.455683e-03 | 2.024 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 9.498106e-03 | 2.022 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.028096e-02 | 1.988 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.076750e-02 | 1.968 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.057330e-02 | 1.976 | 1 | 1 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.102235e-02 | 1.958 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.129202e-02 | 1.947 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.235008e-02 | 1.908 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.273296e-02 | 1.895 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.273296e-02 | 1.895 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.255220e-02 | 1.901 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 1.253141e-02 | 1.902 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.281793e-02 | 1.892 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.337036e-02 | 1.874 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.253141e-02 | 1.902 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.273296e-02 | 1.895 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.253141e-02 | 1.902 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.188622e-02 | 1.925 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.211274e-02 | 1.917 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.273296e-02 | 1.895 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.318819e-02 | 1.880 | 1 | 1 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.337036e-02 | 1.874 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.281031e-02 | 1.892 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.255220e-02 | 1.901 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.363214e-02 | 1.865 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.373006e-02 | 1.862 | 1 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.507875e-02 | 1.822 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.461020e-02 | 1.835 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.423618e-02 | 1.847 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.423618e-02 | 1.847 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.448886e-02 | 1.839 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.551736e-02 | 1.809 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.507875e-02 | 1.822 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.482712e-02 | 1.829 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.490907e-02 | 1.827 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.507875e-02 | 1.822 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.482712e-02 | 1.829 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.589804e-02 | 1.799 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 1.589804e-02 | 1.799 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.607186e-02 | 1.794 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.629125e-02 | 1.788 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.630661e-02 | 1.788 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.725720e-02 | 1.763 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.761097e-02 | 1.754 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.768970e-02 | 1.752 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.851688e-02 | 1.732 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 1.852793e-02 | 1.732 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.097709e-02 | 1.678 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.097709e-02 | 1.678 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.097709e-02 | 1.678 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.097709e-02 | 1.678 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.097709e-02 | 1.678 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.009416e-02 | 1.697 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.007545e-02 | 1.697 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.973048e-02 | 1.705 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 2.007545e-02 | 1.697 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.009416e-02 | 1.697 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.917701e-02 | 1.717 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.023779e-02 | 1.694 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.125747e-02 | 1.672 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.249565e-02 | 1.648 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.249565e-02 | 1.648 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.357275e-02 | 1.628 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.498488e-02 | 1.602 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.528829e-02 | 1.597 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.559454e-02 | 1.592 | 1 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.610460e-02 | 1.583 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.662566e-02 | 1.575 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.938886e-02 | 1.532 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.938886e-02 | 1.532 | 1 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.644675e-02 | 1.578 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.857916e-02 | 1.544 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.888941e-02 | 1.539 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.644090e-02 | 1.578 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.691725e-02 | 1.570 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 2.759033e-02 | 1.559 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 2.954052e-02 | 1.530 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 2.954052e-02 | 1.530 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.958196e-02 | 1.529 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.970366e-02 | 1.527 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 3.012563e-02 | 1.521 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 3.119644e-02 | 1.506 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.138368e-02 | 1.503 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 3.217016e-02 | 1.493 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.235368e-02 | 1.490 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.369112e-02 | 1.472 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 3.369112e-02 | 1.472 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.781874e-02 | 1.422 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.606198e-02 | 1.443 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.735229e-02 | 1.428 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.851152e-02 | 1.414 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.781874e-02 | 1.422 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.437740e-02 | 1.464 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.521157e-02 | 1.453 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.703336e-02 | 1.431 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.850023e-02 | 1.415 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.829155e-02 | 1.417 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.477854e-02 | 1.459 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.656110e-02 | 1.437 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.781874e-02 | 1.422 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.851152e-02 | 1.414 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.864276e-02 | 1.413 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.864276e-02 | 1.413 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.874778e-02 | 1.412 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.892596e-02 | 1.410 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.937001e-02 | 1.405 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.944069e-02 | 1.404 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.944069e-02 | 1.404 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 4.332936e-02 | 1.363 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 4.332936e-02 | 1.363 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 4.525717e-02 | 1.344 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 4.083240e-02 | 1.389 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 4.027704e-02 | 1.395 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 4.027704e-02 | 1.395 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 4.027704e-02 | 1.395 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 4.027704e-02 | 1.395 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.139005e-02 | 1.383 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 4.614336e-02 | 1.336 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.587135e-02 | 1.338 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.326286e-02 | 1.364 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 4.181847e-02 | 1.379 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.614336e-02 | 1.336 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.612368e-02 | 1.336 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 4.525717e-02 | 1.344 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.525717e-02 | 1.344 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.027704e-02 | 1.395 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.416283e-02 | 1.355 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 4.415129e-02 | 1.355 | 1 | 1 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.027704e-02 | 1.395 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 4.419638e-02 | 1.355 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 4.083240e-02 | 1.389 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 4.326286e-02 | 1.364 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.620864e-02 | 1.335 | 1 | 1 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.824002e-02 | 1.317 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 4.839766e-02 | 1.315 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.051923e-02 | 1.297 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.051923e-02 | 1.297 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.103085e-02 | 1.292 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.103085e-02 | 1.292 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 5.112852e-02 | 1.291 | 1 | 1 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 5.112852e-02 | 1.291 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 5.112852e-02 | 1.291 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 5.199629e-02 | 1.284 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.203598e-02 | 1.284 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 5.204657e-02 | 1.284 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 5.220267e-02 | 1.282 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 5.274896e-02 | 1.278 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 5.392566e-02 | 1.268 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.530371e-02 | 1.257 | 1 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 5.530371e-02 | 1.257 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.637004e-02 | 1.249 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 5.734411e-02 | 1.242 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 5.876322e-02 | 1.231 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.977267e-02 | 1.223 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 7.098316e-02 | 1.149 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 6.103653e-02 | 1.214 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.103653e-02 | 1.214 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 7.070260e-02 | 1.151 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 6.614937e-02 | 1.179 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 6.540329e-02 | 1.184 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 6.052251e-02 | 1.218 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 6.133751e-02 | 1.212 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.103653e-02 | 1.214 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.940865e-02 | 1.226 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.133751e-02 | 1.212 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 6.706358e-02 | 1.174 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 6.955907e-02 | 1.158 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.015368e-02 | 1.221 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.015368e-02 | 1.221 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 6.419342e-02 | 1.193 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.540329e-02 | 1.184 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 6.126397e-02 | 1.213 | 1 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 6.133751e-02 | 1.212 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 6.619271e-02 | 1.179 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 5.985511e-02 | 1.223 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 7.098316e-02 | 1.149 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 7.053410e-02 | 1.152 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 7.231299e-02 | 1.141 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.382271e-02 | 1.132 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 7.603319e-02 | 1.119 | 1 | 1 |
| Signaling by NTRKs | R-HSA-166520 | 7.709718e-02 | 1.113 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 7.829916e-02 | 1.106 | 0 | 0 |
| Kinesins | R-HSA-983189 | 7.829916e-02 | 1.106 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 7.869174e-02 | 1.104 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 7.869174e-02 | 1.104 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.881938e-02 | 1.103 | 1 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 7.943578e-02 | 1.100 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 8.011117e-02 | 1.096 | 1 | 1 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 8.119820e-02 | 1.090 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 8.119820e-02 | 1.090 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 8.119820e-02 | 1.090 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 8.177969e-02 | 1.087 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 8.257398e-02 | 1.083 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 8.285725e-02 | 1.082 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 1.043175e-01 | 0.982 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 1.043175e-01 | 0.982 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.043175e-01 | 0.982 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.043175e-01 | 0.982 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 9.986158e-02 | 1.001 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 9.986158e-02 | 1.001 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 9.986158e-02 | 1.001 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 8.612192e-02 | 1.065 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 8.612192e-02 | 1.065 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 8.612192e-02 | 1.065 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.026868e-01 | 0.988 | 1 | 1 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.026868e-01 | 0.988 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.026868e-01 | 0.988 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.026868e-01 | 0.988 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.026868e-01 | 0.988 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.026868e-01 | 0.988 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.026868e-01 | 0.988 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 8.520468e-02 | 1.070 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 9.872023e-02 | 1.006 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 9.872023e-02 | 1.006 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 9.872023e-02 | 1.006 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.251357e-02 | 1.034 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.567105e-02 | 1.067 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 8.567105e-02 | 1.067 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 8.567105e-02 | 1.067 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.713794e-02 | 1.013 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.017263e-01 | 0.993 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.970621e-02 | 1.001 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.041237e-01 | 0.982 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.251357e-02 | 1.034 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 8.821078e-02 | 1.054 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 9.713794e-02 | 1.013 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 8.520468e-02 | 1.070 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.024640e-01 | 0.989 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.771329e-02 | 1.057 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.393261e-02 | 1.027 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 8.918970e-02 | 1.050 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 8.487117e-02 | 1.071 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 8.821078e-02 | 1.054 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 9.872023e-02 | 1.006 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.251357e-02 | 1.034 | 0 | 0 |
| Signaling by FGFR1 amplification mutants | R-HSA-1839120 | 1.059688e-01 | 0.975 | 0 | 0 |
| Signaling by FGFR2 amplification mutants | R-HSA-2023837 | 1.059688e-01 | 0.975 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.059688e-01 | 0.975 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.060181e-01 | 0.975 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.060181e-01 | 0.975 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 1.069252e-01 | 0.971 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.069252e-01 | 0.971 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 1.071125e-01 | 0.970 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 1.071125e-01 | 0.970 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 1.071125e-01 | 0.970 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.071125e-01 | 0.970 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.071125e-01 | 0.970 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.071125e-01 | 0.970 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.071125e-01 | 0.970 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.423447e-01 | 0.847 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 1.423447e-01 | 0.847 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 1.423447e-01 | 0.847 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.230282e-01 | 0.910 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 1.230282e-01 | 0.910 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.230282e-01 | 0.910 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 1.230282e-01 | 0.910 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.230282e-01 | 0.910 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.205869e-01 | 0.919 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.397175e-01 | 0.855 | 1 | 1 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.132423e-01 | 0.946 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.287228e-01 | 0.890 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.185175e-01 | 0.926 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.435435e-01 | 0.843 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.222034e-01 | 0.913 | 1 | 1 |
| Meiotic synapsis | R-HSA-1221632 | 1.418905e-01 | 0.848 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.418905e-01 | 0.848 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.105229e-01 | 0.957 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.365597e-01 | 0.865 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.365597e-01 | 0.865 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.365597e-01 | 0.865 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.365597e-01 | 0.865 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.365597e-01 | 0.865 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.343737e-01 | 0.872 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.429108e-01 | 0.845 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 1.205869e-01 | 0.919 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 1.093359e-01 | 0.961 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.230282e-01 | 0.910 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.222034e-01 | 0.913 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.273112e-01 | 0.895 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.435435e-01 | 0.843 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.311831e-01 | 0.882 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.311831e-01 | 0.882 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.311831e-01 | 0.882 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.261274e-01 | 0.899 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.205869e-01 | 0.919 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.307309e-01 | 0.884 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.318499e-01 | 0.880 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.230282e-01 | 0.910 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.311831e-01 | 0.882 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.402333e-01 | 0.853 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.205869e-01 | 0.919 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.185175e-01 | 0.926 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.307309e-01 | 0.884 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.435435e-01 | 0.843 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.132423e-01 | 0.946 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 1.185175e-01 | 0.926 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.234442e-01 | 0.909 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.099995e-01 | 0.959 | 1 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.408509e-01 | 0.851 | 1 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.363722e-01 | 0.865 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.156282e-01 | 0.937 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.266911e-01 | 0.897 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.128005e-01 | 0.948 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.365597e-01 | 0.865 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.335929e-01 | 0.874 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.362233e-01 | 0.866 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.132423e-01 | 0.946 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.270362e-01 | 0.896 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.174917e-01 | 0.930 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.423447e-01 | 0.847 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.423447e-01 | 0.847 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.266911e-01 | 0.897 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.435435e-01 | 0.843 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.435435e-01 | 0.843 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.205869e-01 | 0.919 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.273112e-01 | 0.895 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.273112e-01 | 0.895 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.435435e-01 | 0.843 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.451058e-01 | 0.838 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.455531e-01 | 0.837 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.455531e-01 | 0.837 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.479222e-01 | 0.830 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 1.479222e-01 | 0.830 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.479222e-01 | 0.830 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.479222e-01 | 0.830 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 1.479222e-01 | 0.830 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.558632e-01 | 0.807 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.569305e-01 | 0.804 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.593790e-01 | 0.798 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.599635e-01 | 0.796 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.599635e-01 | 0.796 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.599635e-01 | 0.796 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 1.599635e-01 | 0.796 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.606032e-01 | 0.794 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.606032e-01 | 0.794 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.606032e-01 | 0.794 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 1.606032e-01 | 0.794 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.608364e-01 | 0.794 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.621949e-01 | 0.790 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.621949e-01 | 0.790 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.623286e-01 | 0.790 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.623286e-01 | 0.790 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 1.623286e-01 | 0.790 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.977583e-01 | 0.704 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 1.977583e-01 | 0.704 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 1.977583e-01 | 0.704 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.977583e-01 | 0.704 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.977583e-01 | 0.704 | 0 | 0 |
| Signaling by FGFR2 fusions | R-HSA-8853333 | 2.814559e-01 | 0.551 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.814559e-01 | 0.551 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 2.814559e-01 | 0.551 | 1 | 1 |
| Defective SLC26A2 causes chondrodysplasias | R-HSA-3560792 | 2.814559e-01 | 0.551 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.814559e-01 | 0.551 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.814559e-01 | 0.551 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 2.814559e-01 | 0.551 | 1 | 1 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 2.814559e-01 | 0.551 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 1.808630e-01 | 0.743 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.206816e-01 | 0.656 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.564258e-01 | 0.448 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 3.564258e-01 | 0.448 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.564258e-01 | 0.448 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.564258e-01 | 0.448 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.742694e-01 | 0.759 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.742694e-01 | 0.759 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 2.611105e-01 | 0.583 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 2.611105e-01 | 0.583 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.611105e-01 | 0.583 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 2.017985e-01 | 0.695 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.017985e-01 | 0.695 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.017985e-01 | 0.695 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.017985e-01 | 0.695 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.017985e-01 | 0.695 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 1.812025e-01 | 0.742 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.812025e-01 | 0.742 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 2.302478e-01 | 0.638 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.302478e-01 | 0.638 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.302478e-01 | 0.638 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 3.015893e-01 | 0.521 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.015893e-01 | 0.521 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.015893e-01 | 0.521 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 3.015893e-01 | 0.521 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.015893e-01 | 0.521 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.015893e-01 | 0.521 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 3.015893e-01 | 0.521 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 4.235776e-01 | 0.373 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.235776e-01 | 0.373 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 4.235776e-01 | 0.373 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.235776e-01 | 0.373 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.235776e-01 | 0.373 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 4.235776e-01 | 0.373 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.235776e-01 | 0.373 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.235776e-01 | 0.373 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 4.235776e-01 | 0.373 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.593686e-01 | 0.586 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.593686e-01 | 0.586 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 2.593686e-01 | 0.586 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.803230e-01 | 0.744 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 1.803230e-01 | 0.744 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.803230e-01 | 0.744 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 3.416681e-01 | 0.466 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 3.416681e-01 | 0.466 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 1.990168e-01 | 0.701 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 1.990168e-01 | 0.701 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 2.889291e-01 | 0.539 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.183343e-01 | 0.661 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 2.093942e-01 | 0.679 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.381983e-01 | 0.623 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.381983e-01 | 0.623 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 2.735399e-01 | 0.563 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.735399e-01 | 0.563 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.809898e-01 | 0.419 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 3.809898e-01 | 0.419 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.809898e-01 | 0.419 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 3.809898e-01 | 0.419 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.809898e-01 | 0.419 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 3.809898e-01 | 0.419 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.837262e-01 | 0.315 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 4.837262e-01 | 0.315 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 4.837262e-01 | 0.315 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.837262e-01 | 0.315 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.837262e-01 | 0.315 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 2.585304e-01 | 0.587 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 2.978363e-01 | 0.526 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.978363e-01 | 0.526 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.978363e-01 | 0.526 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.978363e-01 | 0.526 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.978363e-01 | 0.526 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.978363e-01 | 0.526 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 3.485337e-01 | 0.458 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 3.485337e-01 | 0.458 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.485337e-01 | 0.458 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 3.485337e-01 | 0.458 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 3.485337e-01 | 0.458 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 3.485337e-01 | 0.458 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.742736e-01 | 0.759 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 3.223753e-01 | 0.492 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.192764e-01 | 0.377 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 4.192764e-01 | 0.377 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.976194e-01 | 0.704 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 3.002856e-01 | 0.522 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.002856e-01 | 0.522 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 3.002856e-01 | 0.522 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.338829e-01 | 0.631 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.338829e-01 | 0.631 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 2.810833e-01 | 0.551 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.810833e-01 | 0.551 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 3.782092e-01 | 0.422 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 3.782092e-01 | 0.422 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 3.782092e-01 | 0.422 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.640669e-01 | 0.578 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.215549e-01 | 0.493 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.487776e-01 | 0.604 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.978942e-01 | 0.526 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 3.188134e-01 | 0.496 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 3.188134e-01 | 0.496 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.429860e-01 | 0.465 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.429860e-01 | 0.465 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.563159e-01 | 0.341 | 1 | 1 |
| Degradation of CDH1 | R-HSA-9766229 | 2.951227e-01 | 0.530 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 3.066529e-01 | 0.513 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 4.365326e-01 | 0.360 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.860508e-01 | 0.413 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.366869e-01 | 0.473 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 4.075514e-01 | 0.390 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.959208e-01 | 0.402 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 4.649280e-01 | 0.333 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 4.649280e-01 | 0.333 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 3.854847e-01 | 0.414 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 3.854847e-01 | 0.414 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 4.450371e-01 | 0.352 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.152493e-01 | 0.382 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.152493e-01 | 0.382 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 4.032083e-01 | 0.394 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 4.689303e-01 | 0.329 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 4.252761e-01 | 0.371 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 4.637405e-01 | 0.334 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.792520e-01 | 0.554 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 4.637405e-01 | 0.334 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.663783e-01 | 0.436 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 4.289483e-01 | 0.368 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.798547e-01 | 0.745 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.465955e-01 | 0.608 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 2.183343e-01 | 0.661 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 3.184205e-01 | 0.497 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 4.649280e-01 | 0.333 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.346755e-01 | 0.362 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.232225e-01 | 0.490 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.444660e-01 | 0.612 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 4.152493e-01 | 0.382 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.385675e-01 | 0.358 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.879429e-01 | 0.411 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 3.677790e-01 | 0.434 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.192764e-01 | 0.377 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.002856e-01 | 0.522 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.645073e-01 | 0.438 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.484485e-01 | 0.605 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 4.208232e-01 | 0.376 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.686784e-01 | 0.571 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 2.017985e-01 | 0.695 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.809898e-01 | 0.419 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.626084e-01 | 0.581 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 3.645073e-01 | 0.438 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.803814e-01 | 0.744 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.088418e-01 | 0.388 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.206816e-01 | 0.656 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 1.990168e-01 | 0.701 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 2.183343e-01 | 0.661 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 3.223753e-01 | 0.492 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.192764e-01 | 0.377 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 3.782092e-01 | 0.422 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 4.152493e-01 | 0.382 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.130016e-01 | 0.384 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 2.792520e-01 | 0.554 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 4.649280e-01 | 0.333 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 3.879429e-01 | 0.411 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.828413e-01 | 0.417 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 4.534032e-01 | 0.344 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.708638e-01 | 0.767 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.593686e-01 | 0.586 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 4.075873e-01 | 0.390 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 4.712066e-01 | 0.327 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 2.593686e-01 | 0.586 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 3.416681e-01 | 0.466 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 2.381983e-01 | 0.623 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.924811e-01 | 0.406 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 3.416681e-01 | 0.466 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 4.837262e-01 | 0.315 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.002856e-01 | 0.522 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 3.002856e-01 | 0.522 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.429860e-01 | 0.465 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 4.075873e-01 | 0.390 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.969452e-01 | 0.706 | 1 | 0 |
| PKA activation | R-HSA-163615 | 4.649280e-01 | 0.333 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.189601e-01 | 0.496 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.194476e-01 | 0.659 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.750662e-01 | 0.757 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.184774e-01 | 0.497 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 4.044462e-01 | 0.393 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 2.593686e-01 | 0.586 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.593686e-01 | 0.586 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.803230e-01 | 0.744 | 0 | 0 |
| Protein folding | R-HSA-391251 | 4.490810e-01 | 0.348 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 3.865190e-01 | 0.413 | 1 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.441185e-01 | 0.353 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.032083e-01 | 0.394 | 1 | 1 |
| Interleukin-27 signaling | R-HSA-9020956 | 1.742694e-01 | 0.759 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.579990e-01 | 0.339 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.105611e-01 | 0.677 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.317512e-01 | 0.635 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.219868e-01 | 0.375 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 1.808630e-01 | 0.743 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 1.808630e-01 | 0.743 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.033080e-01 | 0.692 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 3.416681e-01 | 0.466 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.183343e-01 | 0.661 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.585304e-01 | 0.587 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.156226e-01 | 0.666 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 2.792520e-01 | 0.554 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 1.891268e-01 | 0.723 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 4.563159e-01 | 0.341 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.289483e-01 | 0.368 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 4.289483e-01 | 0.368 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 4.807452e-01 | 0.318 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.127823e-01 | 0.672 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.767972e-01 | 0.424 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 2.496040e-01 | 0.603 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 4.152493e-01 | 0.382 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 4.152493e-01 | 0.382 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 4.749906e-01 | 0.323 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 3.470452e-01 | 0.460 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.018520e-01 | 0.695 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.093942e-01 | 0.679 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 3.809898e-01 | 0.419 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.349658e-01 | 0.629 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 4.450371e-01 | 0.352 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.996932e-01 | 0.398 | 1 | 1 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.903723e-01 | 0.409 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 4.501843e-01 | 0.347 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 2.302478e-01 | 0.638 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.593686e-01 | 0.586 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.593686e-01 | 0.586 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.593686e-01 | 0.586 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.416681e-01 | 0.466 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.978363e-01 | 0.526 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.626084e-01 | 0.581 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.629091e-01 | 0.580 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 4.075873e-01 | 0.390 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.563159e-01 | 0.341 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.306830e-01 | 0.481 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 4.689303e-01 | 0.329 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 2.810833e-01 | 0.551 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.429860e-01 | 0.465 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.794324e-01 | 0.554 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 3.717406e-01 | 0.430 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 3.700967e-01 | 0.432 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.689303e-01 | 0.329 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.585304e-01 | 0.587 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.268360e-01 | 0.644 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.978363e-01 | 0.526 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 3.485337e-01 | 0.458 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 3.485337e-01 | 0.458 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.379617e-01 | 0.471 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 3.734421e-01 | 0.428 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.702347e-01 | 0.432 | 1 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.903554e-01 | 0.309 | 1 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 2.002440e-01 | 0.698 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 2.279644e-01 | 0.642 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.809898e-01 | 0.419 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.479647e-01 | 0.606 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.702347e-01 | 0.432 | 1 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 2.639749e-01 | 0.578 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.665023e-01 | 0.779 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.474609e-01 | 0.606 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.147531e-01 | 0.382 | 1 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.671698e-01 | 0.573 | 1 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.904940e-01 | 0.408 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.215549e-01 | 0.493 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 4.450371e-01 | 0.352 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.121598e-01 | 0.673 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.977583e-01 | 0.704 | 0 | 0 |
| SDK interactions | R-HSA-373756 | 1.977583e-01 | 0.704 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.814559e-01 | 0.551 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.206816e-01 | 0.656 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.564258e-01 | 0.448 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.564258e-01 | 0.448 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.564258e-01 | 0.448 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.564258e-01 | 0.448 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 3.564258e-01 | 0.448 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.015893e-01 | 0.521 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 4.235776e-01 | 0.373 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 4.235776e-01 | 0.373 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 4.235776e-01 | 0.373 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.416681e-01 | 0.466 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 3.416681e-01 | 0.466 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.496040e-01 | 0.603 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 2.496040e-01 | 0.603 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.183343e-01 | 0.661 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.381983e-01 | 0.623 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 3.187155e-01 | 0.497 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.837262e-01 | 0.315 | 0 | 0 |
| GABA synthesis | R-HSA-888568 | 4.837262e-01 | 0.315 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.837262e-01 | 0.315 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.156226e-01 | 0.666 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 2.792520e-01 | 0.554 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 3.223753e-01 | 0.492 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 2.640669e-01 | 0.578 | 1 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 2.640669e-01 | 0.578 | 1 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.717033e-01 | 0.765 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.849879e-01 | 0.733 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 4.365326e-01 | 0.360 | 1 | 1 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 4.152493e-01 | 0.382 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.170292e-01 | 0.380 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 4.712066e-01 | 0.327 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 4.191673e-01 | 0.378 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.808541e-01 | 0.552 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.162048e-01 | 0.500 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 3.143877e-01 | 0.503 | 1 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.718330e-01 | 0.566 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.912520e-01 | 0.718 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.209141e-01 | 0.376 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 2.405615e-01 | 0.619 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 4.653228e-01 | 0.332 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 3.187155e-01 | 0.497 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.208232e-01 | 0.376 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.566713e-01 | 0.448 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.485337e-01 | 0.458 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.797231e-01 | 0.553 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.209141e-01 | 0.376 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 2.017985e-01 | 0.695 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.093942e-01 | 0.679 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 3.187155e-01 | 0.497 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.809898e-01 | 0.419 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.772822e-01 | 0.557 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.862409e-01 | 0.730 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.041396e-01 | 0.690 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.583449e-01 | 0.588 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.808541e-01 | 0.552 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 2.267101e-01 | 0.645 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 2.735399e-01 | 0.563 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.585304e-01 | 0.587 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.193092e-01 | 0.659 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 3.645073e-01 | 0.438 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.734421e-01 | 0.428 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.206816e-01 | 0.656 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 3.717406e-01 | 0.430 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 3.671802e-01 | 0.435 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 4.416707e-01 | 0.355 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.360591e-01 | 0.627 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.501285e-01 | 0.456 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 2.314116e-01 | 0.636 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.654704e-01 | 0.576 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.187155e-01 | 0.497 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 3.825360e-01 | 0.417 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 4.289483e-01 | 0.368 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.289021e-01 | 0.483 | 1 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.645073e-01 | 0.438 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 2.261513e-01 | 0.646 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.918444e-01 | 0.535 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.279303e-01 | 0.484 | 1 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.663695e-01 | 0.779 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.663695e-01 | 0.779 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.814559e-01 | 0.551 | 0 | 0 |
| Inhibition of membrane repair | R-HSA-9635644 | 2.814559e-01 | 0.551 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.206816e-01 | 0.656 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 3.416681e-01 | 0.466 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.837262e-01 | 0.315 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 3.223753e-01 | 0.492 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 4.192764e-01 | 0.377 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 4.192764e-01 | 0.377 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 4.563159e-01 | 0.341 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.918719e-01 | 0.535 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.365326e-01 | 0.360 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 4.208232e-01 | 0.376 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 4.075514e-01 | 0.390 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 4.289483e-01 | 0.368 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 4.605739e-01 | 0.337 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.823850e-01 | 0.739 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 3.923956e-01 | 0.406 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 2.889291e-01 | 0.539 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 4.192764e-01 | 0.377 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 3.645073e-01 | 0.438 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 4.365326e-01 | 0.360 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 2.611105e-01 | 0.583 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.017985e-01 | 0.695 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.990168e-01 | 0.701 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.496040e-01 | 0.603 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 3.187155e-01 | 0.497 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.809898e-01 | 0.419 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 4.563159e-01 | 0.341 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 4.594380e-01 | 0.338 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.735399e-01 | 0.563 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 3.223753e-01 | 0.492 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 2.206816e-01 | 0.656 | 0 | 0 |
| Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells | R-HSA-210746 | 2.611105e-01 | 0.583 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 2.593686e-01 | 0.586 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 1.925710e-01 | 0.715 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 3.809898e-01 | 0.419 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 4.837262e-01 | 0.315 | 0 | 0 |
| Transmission across Electrical Synapses | R-HSA-112307 | 4.837262e-01 | 0.315 | 0 | 0 |
| Electric Transmission Across Gap Junctions | R-HSA-112303 | 4.837262e-01 | 0.315 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.192764e-01 | 0.377 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 3.782092e-01 | 0.422 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.563159e-01 | 0.341 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.066018e-01 | 0.685 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.475727e-01 | 0.606 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.223753e-01 | 0.492 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 4.649280e-01 | 0.333 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 3.432757e-01 | 0.464 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.192764e-01 | 0.377 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.249450e-01 | 0.488 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 3.015893e-01 | 0.521 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 3.015893e-01 | 0.521 | 0 | 0 |
| Expression and Processing of Neurotrophins | R-HSA-9036866 | 4.235776e-01 | 0.373 | 0 | 0 |
| NGF processing | R-HSA-167060 | 4.235776e-01 | 0.373 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 3.187155e-01 | 0.497 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.809898e-01 | 0.419 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.809898e-01 | 0.419 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 2.213364e-01 | 0.655 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 1.911391e-01 | 0.719 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 2.097748e-01 | 0.678 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 3.485337e-01 | 0.458 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 3.432757e-01 | 0.464 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.242734e-01 | 0.489 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 4.365326e-01 | 0.360 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 3.066529e-01 | 0.513 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 2.889291e-01 | 0.539 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.883415e-01 | 0.540 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 4.365326e-01 | 0.360 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 3.570505e-01 | 0.447 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 3.187155e-01 | 0.497 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.223753e-01 | 0.492 | 0 | 0 |
| Synthesis and processing of ENV and VPU | R-HSA-171286 | 3.564258e-01 | 0.448 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 3.002856e-01 | 0.522 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 2.475727e-01 | 0.606 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 1.808630e-01 | 0.743 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.914343e-01 | 0.309 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 4.919517e-01 | 0.308 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.919517e-01 | 0.308 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.919517e-01 | 0.308 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.919517e-01 | 0.308 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.919517e-01 | 0.308 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.919517e-01 | 0.308 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 4.919517e-01 | 0.308 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 4.919665e-01 | 0.308 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 4.924356e-01 | 0.308 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 4.926737e-01 | 0.307 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 4.926737e-01 | 0.307 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.926737e-01 | 0.307 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 4.926737e-01 | 0.307 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 4.926737e-01 | 0.307 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.978247e-01 | 0.303 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 4.986158e-01 | 0.302 | 1 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 4.986158e-01 | 0.302 | 1 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 4.994727e-01 | 0.301 | 1 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 5.003636e-01 | 0.301 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.035710e-01 | 0.298 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.048701e-01 | 0.297 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.063360e-01 | 0.296 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 5.124194e-01 | 0.290 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.154935e-01 | 0.288 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 5.154935e-01 | 0.288 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 5.177018e-01 | 0.286 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 5.196862e-01 | 0.284 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 5.196862e-01 | 0.284 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.197734e-01 | 0.284 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 5.221554e-01 | 0.282 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.235579e-01 | 0.281 | 1 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 5.248079e-01 | 0.280 | 1 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.260737e-01 | 0.279 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.260737e-01 | 0.279 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 5.260737e-01 | 0.279 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.260737e-01 | 0.279 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.260737e-01 | 0.279 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.260737e-01 | 0.279 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.283188e-01 | 0.277 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 5.283188e-01 | 0.277 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 5.325253e-01 | 0.274 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 5.329853e-01 | 0.273 | 1 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 5.329853e-01 | 0.273 | 1 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 5.371490e-01 | 0.270 | 1 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.376016e-01 | 0.270 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.376016e-01 | 0.270 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.376016e-01 | 0.270 | 0 | 0 |
| IRS activation | R-HSA-74713 | 5.376016e-01 | 0.270 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 5.376016e-01 | 0.270 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.376016e-01 | 0.270 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 5.376016e-01 | 0.270 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 5.376016e-01 | 0.270 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.376016e-01 | 0.270 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 5.376016e-01 | 0.270 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.376016e-01 | 0.270 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.376016e-01 | 0.270 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.376016e-01 | 0.270 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 5.376016e-01 | 0.270 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 5.376016e-01 | 0.270 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 5.376016e-01 | 0.270 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.377929e-01 | 0.269 | 1 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 5.380520e-01 | 0.269 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.380520e-01 | 0.269 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.380520e-01 | 0.269 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.381391e-01 | 0.269 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 5.397171e-01 | 0.268 | 1 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 5.397171e-01 | 0.268 | 1 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 5.397171e-01 | 0.268 | 1 | 0 |
| Reproduction | R-HSA-1474165 | 5.420751e-01 | 0.266 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 5.424668e-01 | 0.266 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 5.458972e-01 | 0.263 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 5.458972e-01 | 0.263 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 5.458972e-01 | 0.263 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 5.458972e-01 | 0.263 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.467037e-01 | 0.262 | 1 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.491120e-01 | 0.260 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.522428e-01 | 0.258 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.522482e-01 | 0.258 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 5.522482e-01 | 0.258 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.532295e-01 | 0.257 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 5.581121e-01 | 0.253 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 5.586096e-01 | 0.253 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 5.586096e-01 | 0.253 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 5.586096e-01 | 0.253 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 5.586096e-01 | 0.253 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 5.586096e-01 | 0.253 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.586096e-01 | 0.253 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.586448e-01 | 0.253 | 1 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 5.600662e-01 | 0.252 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 5.613465e-01 | 0.251 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 5.613465e-01 | 0.251 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 5.646234e-01 | 0.248 | 1 | 0 |
| Glycolysis | R-HSA-70171 | 5.647369e-01 | 0.248 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 5.712521e-01 | 0.243 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 5.712521e-01 | 0.243 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 5.712521e-01 | 0.243 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 5.712521e-01 | 0.243 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 5.715005e-01 | 0.243 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 5.728136e-01 | 0.242 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 5.739031e-01 | 0.241 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 5.770461e-01 | 0.239 | 1 | 1 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.777209e-01 | 0.238 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 5.814980e-01 | 0.235 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 5.858576e-01 | 0.232 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 5.858576e-01 | 0.232 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.858576e-01 | 0.232 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.858576e-01 | 0.232 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.858576e-01 | 0.232 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 5.858576e-01 | 0.232 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.858576e-01 | 0.232 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 5.858576e-01 | 0.232 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.858576e-01 | 0.232 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.858576e-01 | 0.232 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 5.858576e-01 | 0.232 | 0 | 0 |
| Relaxin receptors | R-HSA-444821 | 5.858576e-01 | 0.232 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 5.858576e-01 | 0.232 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 5.858576e-01 | 0.232 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 5.858576e-01 | 0.232 | 1 | 1 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 5.861721e-01 | 0.232 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.895190e-01 | 0.230 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 5.895190e-01 | 0.230 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 5.895190e-01 | 0.230 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 5.904211e-01 | 0.229 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 5.904211e-01 | 0.229 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 5.914653e-01 | 0.228 | 1 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 5.957089e-01 | 0.225 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 5.957089e-01 | 0.225 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.981623e-01 | 0.223 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 6.054882e-01 | 0.218 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 6.137519e-01 | 0.212 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 6.187870e-01 | 0.208 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 6.187870e-01 | 0.208 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.187870e-01 | 0.208 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 6.187870e-01 | 0.208 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 6.187870e-01 | 0.208 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.190259e-01 | 0.208 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 6.192369e-01 | 0.208 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 6.192369e-01 | 0.208 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 6.192369e-01 | 0.208 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.192369e-01 | 0.208 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 6.193167e-01 | 0.208 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 6.247331e-01 | 0.204 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 6.252455e-01 | 0.204 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.267302e-01 | 0.203 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 6.268228e-01 | 0.203 | 1 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 6.290802e-01 | 0.201 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.290802e-01 | 0.201 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 6.290802e-01 | 0.201 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 6.290802e-01 | 0.201 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 6.290802e-01 | 0.201 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 6.290802e-01 | 0.201 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 6.290802e-01 | 0.201 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.290802e-01 | 0.201 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.290802e-01 | 0.201 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.290802e-01 | 0.201 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.290802e-01 | 0.201 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.307783e-01 | 0.200 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 6.418154e-01 | 0.193 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 6.418154e-01 | 0.193 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 6.464195e-01 | 0.189 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.464195e-01 | 0.189 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 6.464195e-01 | 0.189 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 6.464195e-01 | 0.189 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.464195e-01 | 0.189 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 6.464195e-01 | 0.189 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 6.464195e-01 | 0.189 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.464195e-01 | 0.189 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 6.464195e-01 | 0.189 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.464195e-01 | 0.189 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.464195e-01 | 0.189 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 6.464195e-01 | 0.189 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 6.464359e-01 | 0.189 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 6.470479e-01 | 0.189 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 6.506377e-01 | 0.187 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 6.506377e-01 | 0.187 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 6.567933e-01 | 0.183 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 6.608546e-01 | 0.180 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 6.608546e-01 | 0.180 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 6.608546e-01 | 0.180 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 6.608546e-01 | 0.180 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.608546e-01 | 0.180 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 6.608546e-01 | 0.180 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 6.608546e-01 | 0.180 | 1 | 1 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 6.608546e-01 | 0.180 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 6.610262e-01 | 0.180 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 6.611955e-01 | 0.180 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 6.625789e-01 | 0.179 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.634329e-01 | 0.178 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 6.645677e-01 | 0.177 | 0 | 0 |
| Removal of aminoterminal propeptides from gamma-carboxylated proteins | R-HSA-159782 | 6.677941e-01 | 0.175 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.677941e-01 | 0.175 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.677941e-01 | 0.175 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.677941e-01 | 0.175 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.677941e-01 | 0.175 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 6.677941e-01 | 0.175 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.677941e-01 | 0.175 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 6.677941e-01 | 0.175 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.677941e-01 | 0.175 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.695800e-01 | 0.174 | 1 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 6.709944e-01 | 0.173 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 6.724390e-01 | 0.172 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 6.724390e-01 | 0.172 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 6.724390e-01 | 0.172 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.724390e-01 | 0.172 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.724390e-01 | 0.172 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 6.724390e-01 | 0.172 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 6.724390e-01 | 0.172 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 6.724390e-01 | 0.172 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 6.724390e-01 | 0.172 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.770098e-01 | 0.169 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 6.773873e-01 | 0.169 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.803021e-01 | 0.167 | 1 | 0 |
| Influenza Infection | R-HSA-168255 | 6.813498e-01 | 0.167 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.828722e-01 | 0.166 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 6.835857e-01 | 0.165 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 6.840855e-01 | 0.165 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 6.932968e-01 | 0.159 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 6.964814e-01 | 0.157 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 6.964814e-01 | 0.157 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 6.968811e-01 | 0.157 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 6.968811e-01 | 0.157 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 6.968811e-01 | 0.157 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.968811e-01 | 0.157 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 6.968811e-01 | 0.157 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.988305e-01 | 0.156 | 0 | 0 |
| RSK activation | R-HSA-444257 | 7.024693e-01 | 0.153 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.024693e-01 | 0.153 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 7.024693e-01 | 0.153 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.024693e-01 | 0.153 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 7.024693e-01 | 0.153 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.024693e-01 | 0.153 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 7.024693e-01 | 0.153 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.024693e-01 | 0.153 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 7.024693e-01 | 0.153 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 7.024693e-01 | 0.153 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.024693e-01 | 0.153 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.024693e-01 | 0.153 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 7.024693e-01 | 0.153 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.024693e-01 | 0.153 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 7.037766e-01 | 0.153 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.037766e-01 | 0.153 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 7.084983e-01 | 0.150 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 7.084983e-01 | 0.150 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 7.084983e-01 | 0.150 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 7.088467e-01 | 0.149 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 7.118158e-01 | 0.148 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 7.163811e-01 | 0.145 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 7.178594e-01 | 0.144 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 7.197917e-01 | 0.143 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 7.197917e-01 | 0.143 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 7.197917e-01 | 0.143 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 7.197917e-01 | 0.143 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.197917e-01 | 0.143 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 7.197917e-01 | 0.143 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 7.197917e-01 | 0.143 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 7.197917e-01 | 0.143 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 7.197917e-01 | 0.143 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 7.197917e-01 | 0.143 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.211013e-01 | 0.142 | 1 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 7.225151e-01 | 0.141 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 7.225151e-01 | 0.141 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 7.225151e-01 | 0.141 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.293429e-01 | 0.137 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 7.297858e-01 | 0.137 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 7.297858e-01 | 0.137 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 7.306101e-01 | 0.136 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 7.335270e-01 | 0.135 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.335270e-01 | 0.135 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.335270e-01 | 0.135 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 7.335270e-01 | 0.135 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 7.335270e-01 | 0.135 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 7.335270e-01 | 0.135 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.335270e-01 | 0.135 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.335270e-01 | 0.135 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 7.335270e-01 | 0.135 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.335270e-01 | 0.135 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.335270e-01 | 0.135 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 7.335270e-01 | 0.135 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.374412e-01 | 0.132 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.403153e-01 | 0.131 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 7.403153e-01 | 0.131 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.407055e-01 | 0.130 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 7.412241e-01 | 0.130 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 7.412241e-01 | 0.130 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 7.412241e-01 | 0.130 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.458661e-01 | 0.127 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 7.492280e-01 | 0.125 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 7.517276e-01 | 0.124 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 7.542443e-01 | 0.122 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 7.571956e-01 | 0.121 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 7.571956e-01 | 0.121 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.571956e-01 | 0.121 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 7.592031e-01 | 0.120 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 7.594654e-01 | 0.119 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 7.594654e-01 | 0.119 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 7.604150e-01 | 0.119 | 1 | 1 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 7.612372e-01 | 0.118 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.612372e-01 | 0.118 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 7.612372e-01 | 0.118 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.612372e-01 | 0.118 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 7.612372e-01 | 0.118 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.613444e-01 | 0.118 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 7.613444e-01 | 0.118 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.613444e-01 | 0.118 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.613444e-01 | 0.118 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 7.613444e-01 | 0.118 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.613444e-01 | 0.118 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.613444e-01 | 0.118 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 7.613444e-01 | 0.118 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 7.613444e-01 | 0.118 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 7.613444e-01 | 0.118 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.613444e-01 | 0.118 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.613444e-01 | 0.118 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.628947e-01 | 0.118 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 7.677023e-01 | 0.115 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 7.686911e-01 | 0.114 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 7.700617e-01 | 0.113 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.723414e-01 | 0.112 | 1 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 7.735203e-01 | 0.112 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 7.757597e-01 | 0.110 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 7.779127e-01 | 0.109 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.798937e-01 | 0.108 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 7.798937e-01 | 0.108 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 7.798937e-01 | 0.108 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.834124e-01 | 0.106 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 7.862594e-01 | 0.104 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 7.862594e-01 | 0.104 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.862594e-01 | 0.104 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.862594e-01 | 0.104 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 7.862594e-01 | 0.104 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 7.862594e-01 | 0.104 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 7.862594e-01 | 0.104 | 0 | 0 |
| Vitamin B1 (thiamin) metabolism | R-HSA-196819 | 7.862594e-01 | 0.104 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.862594e-01 | 0.104 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 7.869200e-01 | 0.104 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 7.869200e-01 | 0.104 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 7.882876e-01 | 0.103 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 7.969596e-01 | 0.099 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.972586e-01 | 0.098 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.972586e-01 | 0.098 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 8.004404e-01 | 0.097 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 8.085746e-01 | 0.092 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 8.085746e-01 | 0.092 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.085746e-01 | 0.092 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 8.085746e-01 | 0.092 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.085746e-01 | 0.092 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 8.133983e-01 | 0.090 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 8.133983e-01 | 0.090 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 8.133983e-01 | 0.090 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 8.159988e-01 | 0.088 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 8.159988e-01 | 0.088 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.159988e-01 | 0.088 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.159988e-01 | 0.088 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 8.233372e-01 | 0.084 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 8.233372e-01 | 0.084 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 8.233372e-01 | 0.084 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 8.283792e-01 | 0.082 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.283792e-01 | 0.082 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.283792e-01 | 0.082 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 8.283792e-01 | 0.082 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 8.283792e-01 | 0.082 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 8.283792e-01 | 0.082 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 8.283792e-01 | 0.082 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.285612e-01 | 0.082 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.285612e-01 | 0.082 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 8.285612e-01 | 0.082 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 8.285612e-01 | 0.082 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 8.285612e-01 | 0.082 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.285612e-01 | 0.082 | 0 | 0 |
| Gamma-carboxylation, transport, and amino-terminal cleavage of proteins | R-HSA-159854 | 8.285612e-01 | 0.082 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.285612e-01 | 0.082 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.285612e-01 | 0.082 | 1 | 1 |
| Polymerase switching | R-HSA-69091 | 8.285612e-01 | 0.082 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 8.285612e-01 | 0.082 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 8.285612e-01 | 0.082 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.285612e-01 | 0.082 | 1 | 1 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.285612e-01 | 0.082 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.285612e-01 | 0.082 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 8.285612e-01 | 0.082 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 8.285612e-01 | 0.082 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.285612e-01 | 0.082 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 8.286599e-01 | 0.082 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.291574e-01 | 0.081 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 8.319841e-01 | 0.080 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.322694e-01 | 0.080 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.390564e-01 | 0.076 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 8.422673e-01 | 0.075 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 8.422673e-01 | 0.075 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.441562e-01 | 0.074 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.446356e-01 | 0.073 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.446356e-01 | 0.073 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 8.464621e-01 | 0.072 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 8.464621e-01 | 0.072 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 8.464621e-01 | 0.072 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 8.464621e-01 | 0.072 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.464621e-01 | 0.072 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 8.464621e-01 | 0.072 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 8.464621e-01 | 0.072 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.464621e-01 | 0.072 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.464621e-01 | 0.072 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.514653e-01 | 0.070 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.517496e-01 | 0.070 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.517496e-01 | 0.070 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.517496e-01 | 0.070 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.546201e-01 | 0.068 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.551275e-01 | 0.068 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.551275e-01 | 0.068 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.551275e-01 | 0.068 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.595681e-01 | 0.066 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 8.624948e-01 | 0.064 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.624948e-01 | 0.064 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.624948e-01 | 0.064 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 8.624948e-01 | 0.064 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.624948e-01 | 0.064 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 8.624948e-01 | 0.064 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 8.624948e-01 | 0.064 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.624948e-01 | 0.064 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.624948e-01 | 0.064 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 8.624948e-01 | 0.064 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.637268e-01 | 0.064 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 8.651169e-01 | 0.063 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 8.670229e-01 | 0.062 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.670229e-01 | 0.062 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.670229e-01 | 0.062 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.670229e-01 | 0.062 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 8.670229e-01 | 0.062 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.678410e-01 | 0.062 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.699520e-01 | 0.061 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.706650e-01 | 0.060 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.720764e-01 | 0.059 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.720764e-01 | 0.059 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 8.724948e-01 | 0.059 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 8.731153e-01 | 0.059 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.768542e-01 | 0.057 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.768542e-01 | 0.057 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.768542e-01 | 0.057 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 8.768542e-01 | 0.057 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 8.768542e-01 | 0.057 | 1 | 1 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.768542e-01 | 0.057 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.768542e-01 | 0.057 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 8.768542e-01 | 0.057 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 8.768542e-01 | 0.057 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 8.768542e-01 | 0.057 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 8.768542e-01 | 0.057 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.768542e-01 | 0.057 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.780147e-01 | 0.056 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.780147e-01 | 0.056 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 8.780147e-01 | 0.056 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 8.780147e-01 | 0.056 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 8.780147e-01 | 0.056 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.804365e-01 | 0.055 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.804365e-01 | 0.055 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.804365e-01 | 0.055 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 8.807714e-01 | 0.055 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 8.812840e-01 | 0.055 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.812840e-01 | 0.055 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 8.852903e-01 | 0.053 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.881619e-01 | 0.052 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 8.881619e-01 | 0.052 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 8.881619e-01 | 0.052 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.881619e-01 | 0.052 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.885770e-01 | 0.051 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.897148e-01 | 0.051 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 8.897148e-01 | 0.051 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.897148e-01 | 0.051 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.897148e-01 | 0.051 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.897148e-01 | 0.051 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 8.897148e-01 | 0.051 | 1 | 1 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 8.897148e-01 | 0.051 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.897148e-01 | 0.051 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.897148e-01 | 0.051 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.897148e-01 | 0.051 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.897148e-01 | 0.051 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.898965e-01 | 0.051 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.898965e-01 | 0.051 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.898965e-01 | 0.051 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.904821e-01 | 0.050 | 1 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 8.911132e-01 | 0.050 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.933736e-01 | 0.049 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.959320e-01 | 0.048 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 8.959320e-01 | 0.048 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.975210e-01 | 0.047 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 8.975210e-01 | 0.047 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.975210e-01 | 0.047 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.979450e-01 | 0.047 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 8.994835e-01 | 0.046 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.011541e-01 | 0.045 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.012330e-01 | 0.045 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 9.012330e-01 | 0.045 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 9.012330e-01 | 0.045 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 9.012330e-01 | 0.045 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 9.012330e-01 | 0.045 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 9.012330e-01 | 0.045 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 9.012330e-01 | 0.045 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 9.012330e-01 | 0.045 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.012330e-01 | 0.045 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 9.012330e-01 | 0.045 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.028565e-01 | 0.044 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.054596e-01 | 0.043 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.054596e-01 | 0.043 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.054596e-01 | 0.043 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.054596e-01 | 0.043 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.059839e-01 | 0.043 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.062719e-01 | 0.043 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.103260e-01 | 0.041 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.108058e-01 | 0.041 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 9.115489e-01 | 0.040 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 9.115489e-01 | 0.040 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.115489e-01 | 0.040 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.115489e-01 | 0.040 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.115489e-01 | 0.040 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.124697e-01 | 0.040 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.124697e-01 | 0.040 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.140876e-01 | 0.039 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.152109e-01 | 0.038 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.154926e-01 | 0.038 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.181043e-01 | 0.037 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 9.189265e-01 | 0.037 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.190038e-01 | 0.037 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.207878e-01 | 0.036 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.207878e-01 | 0.036 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.212429e-01 | 0.036 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 9.253488e-01 | 0.034 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.266394e-01 | 0.033 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 9.290622e-01 | 0.032 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 9.290622e-01 | 0.032 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 9.290622e-01 | 0.032 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.290622e-01 | 0.032 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 9.290622e-01 | 0.032 | 1 | 1 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.290622e-01 | 0.032 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.290622e-01 | 0.032 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.290622e-01 | 0.032 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.290622e-01 | 0.032 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 9.301176e-01 | 0.031 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.307531e-01 | 0.031 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.307531e-01 | 0.031 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.307531e-01 | 0.031 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.307531e-01 | 0.031 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.307531e-01 | 0.031 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.342871e-01 | 0.030 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.343879e-01 | 0.029 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.346128e-01 | 0.029 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.346128e-01 | 0.029 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.346128e-01 | 0.029 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.360201e-01 | 0.029 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.364433e-01 | 0.029 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.364433e-01 | 0.029 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 9.364727e-01 | 0.029 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.364727e-01 | 0.029 | 0 | 0 |
| Melanin biosynthesis | R-HSA-5662702 | 9.364727e-01 | 0.029 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.364727e-01 | 0.029 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.364727e-01 | 0.029 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.365805e-01 | 0.028 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 9.388472e-01 | 0.027 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.399557e-01 | 0.027 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.399557e-01 | 0.027 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.399557e-01 | 0.027 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.408851e-01 | 0.026 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.419928e-01 | 0.026 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.428334e-01 | 0.026 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.431094e-01 | 0.025 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.431094e-01 | 0.025 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.431094e-01 | 0.025 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.431094e-01 | 0.025 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.431094e-01 | 0.025 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 9.431094e-01 | 0.025 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.431094e-01 | 0.025 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.435107e-01 | 0.025 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.435107e-01 | 0.025 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.435107e-01 | 0.025 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.451575e-01 | 0.024 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.457203e-01 | 0.024 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.490532e-01 | 0.023 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.490532e-01 | 0.023 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.490532e-01 | 0.023 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.490532e-01 | 0.023 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.499283e-01 | 0.022 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.543011e-01 | 0.020 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.543763e-01 | 0.020 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.543763e-01 | 0.020 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.543763e-01 | 0.020 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 9.543763e-01 | 0.020 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.552653e-01 | 0.020 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.572189e-01 | 0.019 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.591435e-01 | 0.018 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.591435e-01 | 0.018 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 9.591435e-01 | 0.018 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.601629e-01 | 0.018 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.605787e-01 | 0.017 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.605787e-01 | 0.017 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.607515e-01 | 0.017 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.619754e-01 | 0.017 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.619754e-01 | 0.017 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.619754e-01 | 0.017 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.619754e-01 | 0.017 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.620848e-01 | 0.017 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.633199e-01 | 0.016 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.634128e-01 | 0.016 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.634128e-01 | 0.016 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.634128e-01 | 0.016 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.634128e-01 | 0.016 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 9.636894e-01 | 0.016 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.636894e-01 | 0.016 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.636894e-01 | 0.016 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.641748e-01 | 0.016 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.648422e-01 | 0.016 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.668613e-01 | 0.015 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.672362e-01 | 0.014 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.672362e-01 | 0.014 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.672362e-01 | 0.014 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.672362e-01 | 0.014 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.672362e-01 | 0.014 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.672362e-01 | 0.014 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.678482e-01 | 0.014 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.678912e-01 | 0.014 | 1 | 1 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.684035e-01 | 0.014 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.684035e-01 | 0.014 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.692298e-01 | 0.014 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.699376e-01 | 0.013 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.706603e-01 | 0.013 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.706603e-01 | 0.013 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.706603e-01 | 0.013 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.706603e-01 | 0.013 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.709258e-01 | 0.013 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.712114e-01 | 0.013 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 9.716904e-01 | 0.012 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.719014e-01 | 0.012 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.720345e-01 | 0.012 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.723898e-01 | 0.012 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.725095e-01 | 0.012 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.736937e-01 | 0.012 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.737267e-01 | 0.012 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.737267e-01 | 0.012 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.737267e-01 | 0.012 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.737778e-01 | 0.012 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.737778e-01 | 0.012 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.737778e-01 | 0.012 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.739638e-01 | 0.011 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.745900e-01 | 0.011 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.745900e-01 | 0.011 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.754790e-01 | 0.011 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.761224e-01 | 0.010 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.761224e-01 | 0.010 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.764728e-01 | 0.010 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.782636e-01 | 0.010 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 9.789320e-01 | 0.009 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.789320e-01 | 0.009 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.789320e-01 | 0.009 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.789320e-01 | 0.009 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.789320e-01 | 0.009 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.793696e-01 | 0.009 | 1 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.797884e-01 | 0.009 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.802182e-01 | 0.009 | 1 | 1 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.802182e-01 | 0.009 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.802182e-01 | 0.009 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.802182e-01 | 0.009 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.802182e-01 | 0.009 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.806381e-01 | 0.008 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.808626e-01 | 0.008 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.811343e-01 | 0.008 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.814369e-01 | 0.008 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.820018e-01 | 0.008 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.828266e-01 | 0.008 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.828266e-01 | 0.008 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.828266e-01 | 0.008 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.829185e-01 | 0.007 | 1 | 1 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.829564e-01 | 0.007 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.831065e-01 | 0.007 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.831065e-01 | 0.007 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.831065e-01 | 0.007 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.836288e-01 | 0.007 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.843565e-01 | 0.007 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.848726e-01 | 0.007 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.848726e-01 | 0.007 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.848726e-01 | 0.007 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.854416e-01 | 0.006 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.856460e-01 | 0.006 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.864542e-01 | 0.006 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.864585e-01 | 0.006 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.864650e-01 | 0.006 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.864650e-01 | 0.006 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.872438e-01 | 0.006 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.877555e-01 | 0.005 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.878705e-01 | 0.005 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.878705e-01 | 0.005 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.878705e-01 | 0.005 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.882574e-01 | 0.005 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.883468e-01 | 0.005 | 1 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.888204e-01 | 0.005 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.888204e-01 | 0.005 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.888204e-01 | 0.005 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.891388e-01 | 0.005 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.891388e-01 | 0.005 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.891388e-01 | 0.005 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.891388e-01 | 0.005 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.891388e-01 | 0.005 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.894860e-01 | 0.005 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.898430e-01 | 0.004 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.898548e-01 | 0.004 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.902745e-01 | 0.004 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.902745e-01 | 0.004 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.902745e-01 | 0.004 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.902745e-01 | 0.004 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.906565e-01 | 0.004 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.908903e-01 | 0.004 | 1 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.909118e-01 | 0.004 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.912916e-01 | 0.004 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.916216e-01 | 0.004 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.916216e-01 | 0.004 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.916377e-01 | 0.004 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.922023e-01 | 0.003 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.922023e-01 | 0.003 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.922023e-01 | 0.003 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.922023e-01 | 0.003 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.922023e-01 | 0.003 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.922023e-01 | 0.003 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.922023e-01 | 0.003 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.923928e-01 | 0.003 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.925848e-01 | 0.003 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.926752e-01 | 0.003 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.928609e-01 | 0.003 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.930179e-01 | 0.003 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.930179e-01 | 0.003 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.944021e-01 | 0.002 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.944021e-01 | 0.002 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.944021e-01 | 0.002 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.949877e-01 | 0.002 | 1 | 1 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.954246e-01 | 0.002 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.955120e-01 | 0.002 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.955120e-01 | 0.002 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.957551e-01 | 0.002 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.957551e-01 | 0.002 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.957551e-01 | 0.002 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.958170e-01 | 0.002 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.958170e-01 | 0.002 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.959816e-01 | 0.002 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.959816e-01 | 0.002 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.963468e-01 | 0.002 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.963970e-01 | 0.002 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.964020e-01 | 0.002 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.967784e-01 | 0.001 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.967784e-01 | 0.001 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.968079e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.968562e-01 | 0.001 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.968872e-01 | 0.001 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.971269e-01 | 0.001 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.972594e-01 | 0.001 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.973613e-01 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.976459e-01 | 0.001 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.976876e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.978674e-01 | 0.001 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.979296e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.979296e-01 | 0.001 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.981098e-01 | 0.001 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.981463e-01 | 0.001 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.981463e-01 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.981514e-01 | 0.001 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.982642e-01 | 0.001 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.982642e-01 | 0.001 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.983404e-01 | 0.001 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.984158e-01 | 0.001 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.985141e-01 | 0.001 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.985141e-01 | 0.001 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.987015e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.988246e-01 | 0.001 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.988335e-01 | 0.001 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.989362e-01 | 0.000 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.989367e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.990280e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.990309e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.990309e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.990890e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.991169e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.991452e-01 | 0.000 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.991452e-01 | 0.000 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.992670e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.993745e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.993866e-01 | 0.000 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.993866e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.994497e-01 | 0.000 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.994508e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.995084e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.995599e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.995935e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.996318e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.996472e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.996472e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.996773e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.996855e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.996968e-01 | 0.000 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.997056e-01 | 0.000 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.997399e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.997469e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.997671e-01 | 0.000 | 1 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.997796e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.998184e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.998184e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.998360e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.998374e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.998374e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.998374e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.998545e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.998697e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.998782e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.998956e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.998965e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.998965e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999060e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999234e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999251e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999251e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.999251e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999254e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999309e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999342e-01 | 0.000 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.999437e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999463e-01 | 0.000 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.999541e-01 | 0.000 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.999570e-01 | 0.000 | 1 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999582e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999615e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999633e-01 | 0.000 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.999726e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999777e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999779e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999799e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999823e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999858e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999870e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.999898e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999916e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.999927e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999929e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999935e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999941e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999949e-01 | 0.000 | 1 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999956e-01 | 0.000 | 1 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999967e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999968e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999972e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999973e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999984e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999987e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999988e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999997e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999997e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999998e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999998e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999999e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999999e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999999e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999999e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 1 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.220446e-16 | 15.654 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 5.551115e-16 | 15.256 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.309264e-14 | 13.637 | 1 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.008704e-14 | 13.522 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 7.394085e-14 | 13.131 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.526557e-13 | 12.816 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.996181e-13 | 12.700 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.778888e-13 | 12.556 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.044542e-13 | 12.393 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 4.729550e-13 | 12.325 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 5.279110e-13 | 12.277 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.432188e-12 | 11.844 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.536327e-12 | 11.814 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.697087e-12 | 11.770 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.131384e-12 | 11.504 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.260059e-12 | 11.487 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 5.786593e-12 | 11.238 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.317735e-11 | 10.880 | 1 | 1 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.660294e-11 | 10.780 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.621703e-11 | 10.790 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 8.184453e-11 | 10.087 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.006054e-10 | 9.522 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 3.101773e-10 | 9.508 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 5.819815e-10 | 9.235 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.085084e-10 | 9.216 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 6.667062e-10 | 9.176 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 6.500467e-10 | 9.187 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 6.946839e-10 | 9.158 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.066848e-09 | 8.972 | 1 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.517586e-09 | 8.819 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.517586e-09 | 8.819 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.806027e-09 | 8.743 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.855946e-09 | 8.731 | 1 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.000963e-09 | 8.699 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.265197e-09 | 8.645 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.912978e-09 | 8.407 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.718534e-08 | 7.765 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.714394e-08 | 7.766 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.865751e-08 | 7.729 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.135474e-08 | 7.671 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 2.353844e-08 | 7.628 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.138286e-08 | 7.503 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.247149e-08 | 7.488 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 3.340008e-08 | 7.476 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.415856e-08 | 7.355 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 8.683664e-08 | 7.061 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 9.530418e-08 | 7.021 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.038177e-07 | 6.984 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.073799e-07 | 6.969 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.780174e-07 | 6.750 | 1 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.858340e-07 | 6.731 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.858340e-07 | 6.731 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.984592e-07 | 6.702 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.381071e-07 | 6.471 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.511187e-07 | 6.455 | 1 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.576682e-07 | 6.447 | 1 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.597758e-07 | 6.444 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 3.727935e-07 | 6.429 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.802677e-07 | 6.420 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 3.961924e-07 | 6.402 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.539096e-07 | 6.343 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 5.077366e-07 | 6.294 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 6.314126e-07 | 6.200 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.382305e-07 | 6.195 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 6.657240e-07 | 6.177 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 7.350002e-07 | 6.134 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 7.684088e-07 | 6.114 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 8.160040e-07 | 6.088 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 8.982300e-07 | 6.047 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 9.961900e-07 | 6.002 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.034025e-06 | 5.985 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.232752e-06 | 5.909 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.281574e-06 | 5.892 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.318429e-06 | 5.880 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.363673e-06 | 5.865 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.390582e-06 | 5.857 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.343719e-06 | 5.872 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.425942e-06 | 5.846 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.511731e-06 | 5.821 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.489094e-06 | 5.827 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.444826e-06 | 5.840 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.608704e-06 | 5.794 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.811793e-06 | 5.742 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.862033e-06 | 5.730 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.859088e-06 | 5.731 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.110700e-06 | 5.676 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.206889e-06 | 5.656 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 2.223085e-06 | 5.653 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 2.805888e-06 | 5.552 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.066384e-06 | 5.513 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.037039e-06 | 5.518 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.217289e-06 | 5.493 | 1 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.247815e-06 | 5.488 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.313950e-06 | 5.480 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 3.487314e-06 | 5.458 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.572563e-06 | 5.447 | 1 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.054386e-06 | 5.392 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.054386e-06 | 5.392 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 4.288506e-06 | 5.368 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 4.584923e-06 | 5.339 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 4.861359e-06 | 5.313 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 5.108845e-06 | 5.292 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 5.541066e-06 | 5.256 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 5.470131e-06 | 5.262 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 5.854104e-06 | 5.233 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 6.157700e-06 | 5.211 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 6.824395e-06 | 5.166 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 7.652452e-06 | 5.116 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 8.562354e-06 | 5.067 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 8.562354e-06 | 5.067 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 8.372254e-06 | 5.077 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.530168e-06 | 5.069 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 9.466257e-06 | 5.024 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 9.571008e-06 | 5.019 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 9.571008e-06 | 5.019 | 1 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.073178e-05 | 4.969 | 1 | 1 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.117267e-05 | 4.952 | 1 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.216923e-05 | 4.915 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.227586e-05 | 4.911 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.244104e-05 | 4.905 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.344817e-05 | 4.871 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.401075e-05 | 4.854 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.411476e-05 | 4.850 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.575113e-05 | 4.803 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.895415e-05 | 4.722 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.929104e-05 | 4.715 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.944659e-05 | 4.711 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.944659e-05 | 4.711 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.001031e-05 | 4.699 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.182587e-05 | 4.661 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.511725e-05 | 4.600 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 2.575903e-05 | 4.589 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.732271e-05 | 4.563 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 3.390917e-05 | 4.470 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.827814e-05 | 4.417 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.827814e-05 | 4.417 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.880092e-05 | 4.411 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 4.335127e-05 | 4.363 | 1 | 1 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.065296e-05 | 4.391 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.990942e-05 | 4.399 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.714292e-05 | 4.327 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.756569e-05 | 4.323 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.287073e-05 | 4.368 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.391656e-05 | 4.357 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 4.655441e-05 | 4.332 | 1 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.929784e-05 | 4.307 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.017128e-05 | 4.300 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 5.620208e-05 | 4.250 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 5.701391e-05 | 4.244 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.868462e-05 | 4.231 | 1 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.136254e-05 | 4.212 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 6.523371e-05 | 4.186 | 1 | 1 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.523371e-05 | 4.186 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.007248e-05 | 4.154 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 7.169068e-05 | 4.145 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 7.349198e-05 | 4.134 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 7.349198e-05 | 4.134 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 7.349198e-05 | 4.134 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 7.343347e-05 | 4.134 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 8.115677e-05 | 4.091 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 8.054599e-05 | 4.094 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 8.429097e-05 | 4.074 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 8.429097e-05 | 4.074 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 9.493678e-05 | 4.023 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 9.527145e-05 | 4.021 | 1 | 1 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.055836e-04 | 3.976 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.055836e-04 | 3.976 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.111983e-04 | 3.954 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.134162e-04 | 3.945 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.135338e-04 | 3.945 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.175069e-04 | 3.930 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.374177e-04 | 3.862 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.367282e-04 | 3.864 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.312757e-04 | 3.882 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.227733e-04 | 3.911 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.255964e-04 | 3.901 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.313649e-04 | 3.882 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.354701e-04 | 3.868 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.270971e-04 | 3.896 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.424625e-04 | 3.846 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.424625e-04 | 3.846 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.424625e-04 | 3.846 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.661180e-04 | 3.780 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.671462e-04 | 3.777 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.677427e-04 | 3.775 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.714882e-04 | 3.766 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.734987e-04 | 3.761 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.750726e-04 | 3.757 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.774066e-04 | 3.751 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.861600e-04 | 3.730 | 1 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.873094e-04 | 3.727 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.932472e-04 | 3.714 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.938444e-04 | 3.713 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.938444e-04 | 3.713 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.981259e-04 | 3.703 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.000728e-04 | 3.699 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 2.299834e-04 | 3.638 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.149242e-04 | 3.668 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.397609e-04 | 3.620 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.507780e-04 | 3.601 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.565953e-04 | 3.591 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.586988e-04 | 3.587 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.622328e-04 | 3.581 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.622328e-04 | 3.581 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.018853e-04 | 3.520 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.126016e-04 | 3.505 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.138947e-04 | 3.503 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.161669e-04 | 3.500 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.161669e-04 | 3.500 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.223189e-04 | 3.492 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.282624e-04 | 3.484 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.335872e-04 | 3.477 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.400782e-04 | 3.468 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.430641e-04 | 3.465 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 3.485111e-04 | 3.458 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 3.580658e-04 | 3.446 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 3.580658e-04 | 3.446 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 3.620703e-04 | 3.441 | 1 | 1 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.861288e-04 | 3.413 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.526516e-04 | 3.453 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.861288e-04 | 3.413 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.899819e-04 | 3.409 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.580658e-04 | 3.446 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.861288e-04 | 3.413 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 3.580658e-04 | 3.446 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 4.097113e-04 | 3.388 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 3.899819e-04 | 3.409 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 4.356615e-04 | 3.361 | 1 | 1 |
| snRNP Assembly | R-HSA-191859 | 4.374159e-04 | 3.359 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.374159e-04 | 3.359 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 4.432294e-04 | 3.353 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 4.432294e-04 | 3.353 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 4.432294e-04 | 3.353 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 4.432294e-04 | 3.353 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.536574e-04 | 3.343 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 4.543891e-04 | 3.343 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 4.584951e-04 | 3.339 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.584951e-04 | 3.339 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 4.728241e-04 | 3.325 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 4.728241e-04 | 3.325 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 4.810918e-04 | 3.318 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 4.838329e-04 | 3.315 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 4.838329e-04 | 3.315 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.846635e-04 | 3.315 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.932332e-04 | 3.307 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.932332e-04 | 3.307 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.932332e-04 | 3.307 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.932332e-04 | 3.307 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.932332e-04 | 3.307 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.932332e-04 | 3.307 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.932332e-04 | 3.307 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.932332e-04 | 3.307 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.932332e-04 | 3.307 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.932332e-04 | 3.307 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.932332e-04 | 3.307 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 5.121453e-04 | 3.291 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 5.150251e-04 | 3.288 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 5.660646e-04 | 3.247 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 5.907747e-04 | 3.229 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 5.907747e-04 | 3.229 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 6.798121e-04 | 3.168 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.136308e-04 | 3.212 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.326220e-04 | 3.199 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 6.072842e-04 | 3.217 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 6.608774e-04 | 3.180 | 1 | 1 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 6.608774e-04 | 3.180 | 1 | 1 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 6.608774e-04 | 3.180 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 6.924165e-04 | 3.160 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 7.087223e-04 | 3.150 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 7.105669e-04 | 3.148 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 7.176938e-04 | 3.144 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 7.176938e-04 | 3.144 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 7.322865e-04 | 3.135 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 7.711345e-04 | 3.113 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.856405e-04 | 3.105 | 1 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.856405e-04 | 3.105 | 1 | 0 |
| Semaphorin interactions | R-HSA-373755 | 8.016789e-04 | 3.096 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.036613e-04 | 3.095 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 8.060447e-04 | 3.094 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 8.122238e-04 | 3.090 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 8.311429e-04 | 3.080 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 8.684207e-04 | 3.061 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 8.916726e-04 | 3.050 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 8.940794e-04 | 3.049 | 1 | 1 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 8.940794e-04 | 3.049 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 9.008633e-04 | 3.045 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 9.008633e-04 | 3.045 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 9.008633e-04 | 3.045 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.118066e-04 | 3.040 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.206648e-04 | 3.036 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.715659e-04 | 3.013 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.010892e-03 | 2.995 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.041717e-03 | 2.982 | 1 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.044654e-03 | 2.981 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.057130e-03 | 2.976 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.100331e-03 | 2.958 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.100331e-03 | 2.958 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.106863e-03 | 2.956 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.113925e-03 | 2.953 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.210015e-03 | 2.917 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.210015e-03 | 2.917 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.215711e-03 | 2.915 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.221476e-03 | 2.913 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.245809e-03 | 2.905 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 1.249617e-03 | 2.903 | 1 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 1.249617e-03 | 2.903 | 1 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.312295e-03 | 2.882 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.583331e-03 | 2.800 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.378088e-03 | 2.861 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.479682e-03 | 2.830 | 1 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.578151e-03 | 2.802 | 1 | 1 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.548613e-03 | 2.810 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.417145e-03 | 2.849 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.694377e-03 | 2.771 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.583496e-03 | 2.800 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.457751e-03 | 2.836 | 1 | 1 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.405680e-03 | 2.852 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.407877e-03 | 2.851 | 1 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.689859e-03 | 2.772 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.696624e-03 | 2.770 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.755614e-03 | 2.756 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.755614e-03 | 2.756 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.759878e-03 | 2.755 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.764601e-03 | 2.753 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.842807e-03 | 2.735 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.846557e-03 | 2.734 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.857782e-03 | 2.731 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.021250e-03 | 2.694 | 1 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.056387e-03 | 2.687 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 2.072875e-03 | 2.683 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 2.072875e-03 | 2.683 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.121896e-03 | 2.673 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.121896e-03 | 2.673 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 2.172595e-03 | 2.663 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.177255e-03 | 2.662 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 2.284625e-03 | 2.641 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 2.295068e-03 | 2.639 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 2.332147e-03 | 2.632 | 1 | 1 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.389083e-03 | 2.622 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 2.463644e-03 | 2.608 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 2.559531e-03 | 2.592 | 1 | 1 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 2.559531e-03 | 2.592 | 1 | 1 |
| Myogenesis | R-HSA-525793 | 2.600214e-03 | 2.585 | 0 | 0 |
| Depurination | R-HSA-73927 | 2.717796e-03 | 2.566 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.824449e-03 | 2.549 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.830642e-03 | 2.548 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 2.864602e-03 | 2.543 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.980986e-03 | 2.526 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.980986e-03 | 2.526 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 3.176328e-03 | 2.498 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.197505e-03 | 2.495 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 3.233531e-03 | 2.490 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 3.263478e-03 | 2.486 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.263478e-03 | 2.486 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.263478e-03 | 2.486 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.361938e-03 | 2.473 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 3.371265e-03 | 2.472 | 0 | 0 |
| Immune System | R-HSA-168256 | 3.537444e-03 | 2.451 | 1 | 0 |
| Reproduction | R-HSA-1474165 | 3.563457e-03 | 2.448 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.698979e-03 | 2.432 | 1 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.700170e-03 | 2.432 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 3.755707e-03 | 2.425 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.761826e-03 | 2.425 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.773142e-03 | 2.423 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 3.811937e-03 | 2.419 | 1 | 1 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.811937e-03 | 2.419 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 4.009429e-03 | 2.397 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 4.009429e-03 | 2.397 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.125661e-03 | 2.385 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.307838e-03 | 2.366 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 4.374288e-03 | 2.359 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 4.374288e-03 | 2.359 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 4.392299e-03 | 2.357 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 4.506841e-03 | 2.346 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.620284e-03 | 2.335 | 1 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 4.956006e-03 | 2.305 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 4.956006e-03 | 2.305 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.959142e-03 | 2.305 | 1 | 1 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 6.520526e-03 | 2.186 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.901787e-03 | 2.229 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.196121e-03 | 2.208 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 6.520526e-03 | 2.186 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 5.984518e-03 | 2.223 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 5.986135e-03 | 2.223 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.560193e-03 | 2.255 | 1 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 5.901787e-03 | 2.229 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.209756e-03 | 2.207 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 6.767360e-03 | 2.170 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.979766e-03 | 2.223 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 6.767360e-03 | 2.170 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 6.748182e-03 | 2.171 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.901787e-03 | 2.229 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.376707e-03 | 2.195 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 6.767360e-03 | 2.170 | 0 | 0 |
| Translation | R-HSA-72766 | 5.480532e-03 | 2.261 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 5.076901e-03 | 2.294 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.520526e-03 | 2.186 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.939513e-03 | 2.226 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.943572e-03 | 2.226 | 1 | 0 |
| Glycolysis | R-HSA-70171 | 5.885096e-03 | 2.230 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 5.560193e-03 | 2.255 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 5.979766e-03 | 2.223 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 5.979766e-03 | 2.223 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 6.911005e-03 | 2.160 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 7.213457e-03 | 2.142 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 7.587604e-03 | 2.120 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 7.587604e-03 | 2.120 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 7.731032e-03 | 2.112 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 7.731032e-03 | 2.112 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.984856e-03 | 2.098 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 8.131765e-03 | 2.090 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 8.439672e-03 | 2.074 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.439672e-03 | 2.074 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 8.503332e-03 | 2.070 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.579325e-03 | 2.067 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 8.795267e-03 | 2.056 | 1 | 1 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 8.795267e-03 | 2.056 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 8.795267e-03 | 2.056 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 8.821746e-03 | 2.054 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 8.821746e-03 | 2.054 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 9.123971e-03 | 2.040 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.275461e-03 | 2.033 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 9.595409e-03 | 2.018 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.827338e-03 | 2.008 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.982007e-03 | 2.001 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.010775e-02 | 1.995 | 1 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.010775e-02 | 1.995 | 1 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.010775e-02 | 1.995 | 1 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.040344e-02 | 1.983 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.040344e-02 | 1.983 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.040344e-02 | 1.983 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.070240e-02 | 1.971 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.100662e-02 | 1.958 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.122050e-02 | 1.950 | 1 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.135459e-02 | 1.945 | 1 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.187705e-02 | 1.925 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.187705e-02 | 1.925 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.195546e-02 | 1.922 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.204876e-02 | 1.919 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.204876e-02 | 1.919 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.216018e-02 | 1.915 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 1.216018e-02 | 1.915 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 1.272553e-02 | 1.895 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.273891e-02 | 1.895 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.340712e-02 | 1.873 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.340712e-02 | 1.873 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.394191e-02 | 1.856 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.394191e-02 | 1.856 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.394191e-02 | 1.856 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.394191e-02 | 1.856 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.394191e-02 | 1.856 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.394191e-02 | 1.856 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.394191e-02 | 1.856 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.409421e-02 | 1.851 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.414880e-02 | 1.849 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.441329e-02 | 1.841 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 1.464888e-02 | 1.834 | 1 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.469676e-02 | 1.833 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.469676e-02 | 1.833 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.487778e-02 | 1.827 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.487778e-02 | 1.827 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.487778e-02 | 1.827 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.487778e-02 | 1.827 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.487778e-02 | 1.827 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.530969e-02 | 1.815 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.532600e-02 | 1.815 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.532600e-02 | 1.815 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.589768e-02 | 1.799 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.603886e-02 | 1.795 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.638144e-02 | 1.786 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.642746e-02 | 1.784 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.666565e-02 | 1.778 | 1 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.670067e-02 | 1.777 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.685224e-02 | 1.773 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.685224e-02 | 1.773 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.685224e-02 | 1.773 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.700793e-02 | 1.769 | 1 | 1 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.730638e-02 | 1.762 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.740109e-02 | 1.759 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.740109e-02 | 1.759 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 1.740109e-02 | 1.759 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.750005e-02 | 1.757 | 1 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.750005e-02 | 1.757 | 1 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.753163e-02 | 1.756 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.784663e-02 | 1.748 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.805233e-02 | 1.743 | 1 | 1 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.845990e-02 | 1.734 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.877030e-02 | 1.727 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.509413e-02 | 1.600 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.509413e-02 | 1.600 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.509413e-02 | 1.600 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.302318e-02 | 1.638 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 2.843321e-02 | 1.546 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.547101e-02 | 1.594 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 2.567815e-02 | 1.590 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.822747e-02 | 1.549 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 2.639517e-02 | 1.578 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.010898e-02 | 1.697 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.233348e-02 | 1.651 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.348052e-02 | 1.629 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.212998e-02 | 1.655 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 2.143037e-02 | 1.669 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 2.958713e-02 | 1.529 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.212998e-02 | 1.655 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.212998e-02 | 1.655 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 2.302318e-02 | 1.638 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.327888e-02 | 1.633 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.958713e-02 | 1.529 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.302318e-02 | 1.638 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.143037e-02 | 1.669 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.150474e-02 | 1.667 | 1 | 0 |
| Protein methylation | R-HSA-8876725 | 2.843321e-02 | 1.546 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.150474e-02 | 1.667 | 1 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.044457e-02 | 1.689 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.143037e-02 | 1.669 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 2.639517e-02 | 1.578 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.483505e-02 | 1.605 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 2.374280e-02 | 1.624 | 1 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.182406e-02 | 1.661 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.302318e-02 | 1.638 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 2.243467e-02 | 1.649 | 1 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.243467e-02 | 1.649 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 2.546377e-02 | 1.594 | 1 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.173833e-02 | 1.663 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.958713e-02 | 1.529 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.855229e-02 | 1.544 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 2.261598e-02 | 1.646 | 1 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.378225e-02 | 1.624 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.501718e-02 | 1.602 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.656787e-02 | 1.576 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.327888e-02 | 1.633 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.467847e-02 | 1.608 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.765891e-02 | 1.558 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.958713e-02 | 1.529 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.311421e-02 | 1.636 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 2.959630e-02 | 1.529 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 2.963156e-02 | 1.528 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.963156e-02 | 1.528 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 2.963156e-02 | 1.528 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 2.998897e-02 | 1.523 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.012151e-02 | 1.521 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 3.158940e-02 | 1.500 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.192718e-02 | 1.496 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 3.192718e-02 | 1.496 | 1 | 1 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 3.292486e-02 | 1.482 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 3.292486e-02 | 1.482 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 3.330082e-02 | 1.478 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 3.330082e-02 | 1.478 | 1 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.354757e-02 | 1.474 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.389847e-02 | 1.470 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.389847e-02 | 1.470 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.425727e-02 | 1.465 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.500194e-02 | 1.456 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.513673e-02 | 1.454 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.513673e-02 | 1.454 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.513673e-02 | 1.454 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.513673e-02 | 1.454 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.513673e-02 | 1.454 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 3.513673e-02 | 1.454 | 1 | 1 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.551188e-02 | 1.450 | 1 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.649531e-02 | 1.438 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.676052e-02 | 1.435 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.676052e-02 | 1.435 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 3.702542e-02 | 1.431 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 3.702542e-02 | 1.431 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.717431e-02 | 1.430 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 3.725134e-02 | 1.429 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 3.828948e-02 | 1.417 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.859710e-02 | 1.413 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 3.859710e-02 | 1.413 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.859710e-02 | 1.413 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 3.859710e-02 | 1.413 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.859710e-02 | 1.413 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 4.028994e-02 | 1.395 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 4.028994e-02 | 1.395 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.028994e-02 | 1.395 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.052465e-02 | 1.392 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 4.052465e-02 | 1.392 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 4.052465e-02 | 1.392 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 4.075832e-02 | 1.390 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.075832e-02 | 1.390 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 4.076919e-02 | 1.390 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 4.076919e-02 | 1.390 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 4.076919e-02 | 1.390 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 4.169734e-02 | 1.380 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.317287e-02 | 1.365 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.370290e-02 | 1.359 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 4.370290e-02 | 1.359 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.434765e-02 | 1.353 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 4.508305e-02 | 1.346 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.589366e-02 | 1.338 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 4.589366e-02 | 1.338 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 4.589366e-02 | 1.338 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.589366e-02 | 1.338 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.656882e-02 | 1.332 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.694326e-02 | 1.328 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 4.694326e-02 | 1.328 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 4.697496e-02 | 1.328 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 4.798119e-02 | 1.319 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.851298e-02 | 1.314 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 4.884710e-02 | 1.311 | 1 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 4.922477e-02 | 1.308 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 4.922477e-02 | 1.308 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 4.957004e-02 | 1.305 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.961160e-02 | 1.304 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 4.969595e-02 | 1.304 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 4.969595e-02 | 1.304 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 4.969595e-02 | 1.304 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.969595e-02 | 1.304 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 4.969595e-02 | 1.304 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.999563e-02 | 1.301 | 0 | 0 |
| Disease | R-HSA-1643685 | 5.093619e-02 | 1.293 | 1 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.314306e-02 | 1.275 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 5.447887e-02 | 1.264 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 5.447887e-02 | 1.264 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 5.516976e-02 | 1.258 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 5.536963e-02 | 1.257 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 5.555667e-02 | 1.255 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 5.555667e-02 | 1.255 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 5.555667e-02 | 1.255 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.761100e-02 | 1.239 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 5.761100e-02 | 1.239 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 5.822422e-02 | 1.235 | 1 | 1 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 5.964635e-02 | 1.224 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 6.044257e-02 | 1.219 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 6.044257e-02 | 1.219 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 6.044257e-02 | 1.219 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.044257e-02 | 1.219 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 6.044257e-02 | 1.219 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.107251e-02 | 1.214 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 6.109801e-02 | 1.214 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 6.109801e-02 | 1.214 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.154300e-02 | 1.211 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.154300e-02 | 1.211 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.173137e-02 | 1.209 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.255177e-02 | 1.204 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 6.255177e-02 | 1.204 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 6.255177e-02 | 1.204 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 6.622668e-02 | 1.179 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 6.622668e-02 | 1.179 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 6.622668e-02 | 1.179 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 6.622668e-02 | 1.179 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 6.790058e-02 | 1.168 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 7.044073e-02 | 1.152 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.323208e-02 | 1.135 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.385342e-02 | 1.132 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 7.385342e-02 | 1.132 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.385342e-02 | 1.132 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 7.385342e-02 | 1.132 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 7.456971e-02 | 1.127 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 7.522304e-02 | 1.124 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.553753e-02 | 1.122 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 7.553753e-02 | 1.122 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 7.553753e-02 | 1.122 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 7.553753e-02 | 1.122 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 7.558520e-02 | 1.122 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 7.558520e-02 | 1.122 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 7.558520e-02 | 1.122 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 7.558520e-02 | 1.122 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 7.608553e-02 | 1.119 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 7.608553e-02 | 1.119 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 7.608553e-02 | 1.119 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 7.787932e-02 | 1.109 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.854854e-02 | 1.105 | 1 | 1 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 7.961153e-02 | 1.099 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 8.020539e-02 | 1.096 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 8.325482e-02 | 1.080 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 8.325482e-02 | 1.080 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 8.387416e-02 | 1.076 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 8.387416e-02 | 1.076 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 8.387416e-02 | 1.076 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 8.387416e-02 | 1.076 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 8.474968e-02 | 1.072 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.480404e-02 | 1.072 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 8.512006e-02 | 1.070 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 9.007877e-02 | 1.045 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.008523e-02 | 1.045 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 9.048086e-02 | 1.043 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 9.048086e-02 | 1.043 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 9.048086e-02 | 1.043 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 1.623215e-01 | 0.790 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.623215e-01 | 0.790 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 1.623215e-01 | 0.790 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.623215e-01 | 0.790 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.623215e-01 | 0.790 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.623215e-01 | 0.790 | 0 | 0 |
| Defective GALM causes GALAC4 | R-HSA-9931929 | 1.623215e-01 | 0.790 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 1.623215e-01 | 0.790 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 9.982213e-02 | 1.001 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 9.982213e-02 | 1.001 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.284639e-01 | 0.891 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 1.284639e-01 | 0.891 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 9.211215e-02 | 1.036 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 9.211215e-02 | 1.036 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 9.211215e-02 | 1.036 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 9.211215e-02 | 1.036 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 9.211215e-02 | 1.036 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 9.211215e-02 | 1.036 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 1.587186e-01 | 0.799 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.587186e-01 | 0.799 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.100373e-01 | 0.958 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 1.039895e-01 | 0.983 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.039895e-01 | 0.983 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.039895e-01 | 0.983 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.493860e-01 | 0.826 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.183565e-01 | 0.927 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.183565e-01 | 0.927 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.705253e-01 | 0.768 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.705253e-01 | 0.768 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.705253e-01 | 0.768 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.705253e-01 | 0.768 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.705253e-01 | 0.768 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.038128e-01 | 0.984 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 1.660436e-01 | 0.780 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.437076e-01 | 0.843 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 1.437076e-01 | 0.843 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.181773e-01 | 0.927 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 1.716753e-01 | 0.765 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.716753e-01 | 0.765 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.279343e-01 | 0.893 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.279343e-01 | 0.893 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 1.279343e-01 | 0.893 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.112579e-01 | 0.954 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.198422e-01 | 0.921 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.781989e-01 | 0.749 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.494441e-01 | 0.826 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.368818e-01 | 0.864 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 9.155865e-02 | 1.038 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.088223e-01 | 0.963 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.437076e-01 | 0.843 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.360778e-01 | 0.866 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.100373e-01 | 0.958 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.685827e-01 | 0.773 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.685827e-01 | 0.773 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 1.587186e-01 | 0.799 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.135406e-02 | 1.039 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.140818e-01 | 0.943 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.677053e-01 | 0.775 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.181773e-01 | 0.927 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.587375e-01 | 0.799 | 1 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.276703e-01 | 0.894 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 9.982213e-02 | 1.001 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 1.335276e-01 | 0.874 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 1.494441e-01 | 0.826 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.200591e-01 | 0.921 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 1.660436e-01 | 0.780 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.427281e-01 | 0.845 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 1.813703e-01 | 0.741 | 1 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.039895e-01 | 0.983 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.248423e-01 | 0.904 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.574357e-01 | 0.803 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.380250e-01 | 0.860 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.136925e-01 | 0.944 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.724386e-01 | 0.763 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.261929e-02 | 1.033 | 1 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 1.305261e-01 | 0.884 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.457284e-02 | 1.024 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 1.477696e-01 | 0.830 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 1.179237e-01 | 0.928 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.293837e-02 | 1.032 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.060067e-01 | 0.975 | 1 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 1.473153e-01 | 0.832 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 9.404955e-02 | 1.027 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.724386e-01 | 0.763 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.404955e-02 | 1.027 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.623215e-01 | 0.790 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 9.982213e-02 | 1.001 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 9.982213e-02 | 1.001 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.705253e-01 | 0.768 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.335276e-01 | 0.874 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.140818e-01 | 0.943 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.735280e-01 | 0.761 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.677053e-01 | 0.775 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 1.042911e-01 | 0.982 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 1.072629e-01 | 0.970 | 1 | 1 |
| Platelet sensitization by LDL | R-HSA-432142 | 1.494441e-01 | 0.826 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 9.211215e-02 | 1.036 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 1.587186e-01 | 0.799 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 1.193730e-01 | 0.923 | 1 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 1.380250e-01 | 0.860 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.203027e-01 | 0.920 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 1.181773e-01 | 0.927 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.075926e-01 | 0.968 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.724669e-01 | 0.763 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 9.982213e-02 | 1.001 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.587186e-01 | 0.799 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.705253e-01 | 0.768 | 1 | 1 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 1.335276e-01 | 0.874 | 1 | 1 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.360778e-01 | 0.866 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 9.135406e-02 | 1.039 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.179237e-01 | 0.928 | 1 | 1 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.708367e-01 | 0.767 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.305261e-01 | 0.884 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.305261e-01 | 0.884 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.598972e-01 | 0.796 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.175658e-01 | 0.930 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.660436e-01 | 0.780 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.181773e-01 | 0.927 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 1.284639e-01 | 0.891 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.716753e-01 | 0.765 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.823146e-01 | 0.739 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.183565e-01 | 0.927 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 1.716753e-01 | 0.765 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 1.323248e-01 | 0.878 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.100373e-01 | 0.958 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.017068e-01 | 0.993 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.183565e-01 | 0.927 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.457284e-02 | 1.024 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.707402e-01 | 0.768 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.494441e-01 | 0.826 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.140818e-01 | 0.943 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 1.574357e-01 | 0.803 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.380250e-01 | 0.860 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.039895e-01 | 0.983 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 1.486084e-01 | 0.828 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.494441e-01 | 0.826 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 1.284639e-01 | 0.891 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.832616e-01 | 0.737 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.832616e-01 | 0.737 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.832616e-01 | 0.737 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.833850e-01 | 0.737 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.833850e-01 | 0.737 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.833850e-01 | 0.737 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.889729e-01 | 0.724 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 1.901075e-01 | 0.721 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 1.901075e-01 | 0.721 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.924527e-01 | 0.716 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.924527e-01 | 0.716 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.924527e-01 | 0.716 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 1.942055e-01 | 0.712 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.964974e-01 | 0.707 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.996350e-01 | 0.700 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.997999e-01 | 0.699 | 1 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 2.010320e-01 | 0.697 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.010320e-01 | 0.697 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.015404e-01 | 0.696 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.063950e-01 | 0.685 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.065421e-01 | 0.685 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.110917e-01 | 0.676 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.113090e-01 | 0.675 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 2.123038e-01 | 0.673 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 2.126248e-01 | 0.672 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.150306e-01 | 0.667 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.150306e-01 | 0.667 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.161488e-01 | 0.665 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.162135e-01 | 0.665 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 2.170881e-01 | 0.663 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.170881e-01 | 0.663 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.192879e-01 | 0.659 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.192879e-01 | 0.659 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 2.192879e-01 | 0.659 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.192879e-01 | 0.659 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 2.192879e-01 | 0.659 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.192879e-01 | 0.659 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 2.192879e-01 | 0.659 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.192879e-01 | 0.659 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.192879e-01 | 0.659 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 2.222214e-01 | 0.653 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 2.222214e-01 | 0.653 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.222214e-01 | 0.653 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 2.222214e-01 | 0.653 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 2.222214e-01 | 0.653 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 2.222214e-01 | 0.653 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 2.222214e-01 | 0.653 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.222214e-01 | 0.653 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 2.222214e-01 | 0.653 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.222214e-01 | 0.653 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 2.222214e-01 | 0.653 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 2.255379e-01 | 0.647 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.262533e-01 | 0.645 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 2.265675e-01 | 0.645 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.273522e-01 | 0.643 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 2.329923e-01 | 0.633 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 2.329923e-01 | 0.633 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.333229e-01 | 0.632 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.333229e-01 | 0.632 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 2.333229e-01 | 0.632 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.333229e-01 | 0.632 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.333229e-01 | 0.632 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.333229e-01 | 0.632 | 0 | 0 |
| Nef mediated downregulation of CD28 cell surface expression | R-HSA-164939 | 2.333229e-01 | 0.632 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.333229e-01 | 0.632 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.333229e-01 | 0.632 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.333229e-01 | 0.632 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.333229e-01 | 0.632 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 2.333229e-01 | 0.632 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 2.362829e-01 | 0.627 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.379624e-01 | 0.623 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 2.379624e-01 | 0.623 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.379624e-01 | 0.623 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 2.381266e-01 | 0.623 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.381266e-01 | 0.623 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.381266e-01 | 0.623 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 2.404884e-01 | 0.619 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 2.404884e-01 | 0.619 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.473406e-01 | 0.607 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.492124e-01 | 0.603 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.543418e-01 | 0.595 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.547124e-01 | 0.594 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 2.547124e-01 | 0.594 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 2.547124e-01 | 0.594 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 2.549812e-01 | 0.593 | 1 | 1 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.549812e-01 | 0.593 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 2.569894e-01 | 0.590 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 2.569894e-01 | 0.590 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.587315e-01 | 0.587 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.587315e-01 | 0.587 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.587315e-01 | 0.587 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.587315e-01 | 0.587 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.587315e-01 | 0.587 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.616146e-01 | 0.582 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.657077e-01 | 0.576 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.657077e-01 | 0.576 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.657077e-01 | 0.576 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.657077e-01 | 0.576 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 2.697038e-01 | 0.569 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 2.697038e-01 | 0.569 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 2.697038e-01 | 0.569 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.697038e-01 | 0.569 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.763040e-01 | 0.559 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.763040e-01 | 0.559 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 2.835720e-01 | 0.547 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 2.853757e-01 | 0.545 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.853757e-01 | 0.545 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 2.872861e-01 | 0.542 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 2.872861e-01 | 0.542 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 2.872861e-01 | 0.542 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 2.872861e-01 | 0.542 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 2.872861e-01 | 0.542 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 2.872861e-01 | 0.542 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 2.872861e-01 | 0.542 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 2.872861e-01 | 0.542 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 2.872861e-01 | 0.542 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 2.872861e-01 | 0.542 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 2.872861e-01 | 0.542 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 2.934411e-01 | 0.532 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 2.958428e-01 | 0.529 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 2.983101e-01 | 0.525 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 2.983101e-01 | 0.525 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 2.983101e-01 | 0.525 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 2.983101e-01 | 0.525 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 2.983101e-01 | 0.525 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 2.983101e-01 | 0.525 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 2.983101e-01 | 0.525 | 0 | 0 |
| Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization | R-HSA-180897 | 2.983101e-01 | 0.525 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 2.983101e-01 | 0.525 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.993613e-01 | 0.524 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.993613e-01 | 0.524 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 2.997252e-01 | 0.523 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.044901e-01 | 0.516 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 3.089938e-01 | 0.510 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 3.092987e-01 | 0.510 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 3.092987e-01 | 0.510 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.092987e-01 | 0.510 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 3.092987e-01 | 0.510 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 3.092987e-01 | 0.510 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 3.092987e-01 | 0.510 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.092987e-01 | 0.510 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.127232e-01 | 0.505 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 3.149680e-01 | 0.502 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 3.149680e-01 | 0.502 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 3.155447e-01 | 0.501 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.155447e-01 | 0.501 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 3.164400e-01 | 0.500 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 3.164400e-01 | 0.500 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.196952e-01 | 0.495 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.196952e-01 | 0.495 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.196952e-01 | 0.495 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 3.196952e-01 | 0.495 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 3.196952e-01 | 0.495 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.196952e-01 | 0.495 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.196952e-01 | 0.495 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.196952e-01 | 0.495 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 3.269662e-01 | 0.485 | 1 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 3.293237e-01 | 0.482 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 3.303284e-01 | 0.481 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 3.303284e-01 | 0.481 | 1 | 1 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.303284e-01 | 0.481 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 3.303284e-01 | 0.481 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 3.303284e-01 | 0.481 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 3.320786e-01 | 0.479 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.320786e-01 | 0.479 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.332803e-01 | 0.477 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 3.332803e-01 | 0.477 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.332803e-01 | 0.477 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.336346e-01 | 0.477 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.336346e-01 | 0.477 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 3.336346e-01 | 0.477 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.353509e-01 | 0.475 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.353509e-01 | 0.475 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.403550e-01 | 0.468 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 3.415946e-01 | 0.466 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 3.457792e-01 | 0.461 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 3.457792e-01 | 0.461 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 3.457792e-01 | 0.461 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 3.481624e-01 | 0.458 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 3.509077e-01 | 0.455 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 3.517339e-01 | 0.454 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 3.517339e-01 | 0.454 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 3.517339e-01 | 0.454 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 3.517339e-01 | 0.454 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 3.517339e-01 | 0.454 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.517339e-01 | 0.454 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 3.517339e-01 | 0.454 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 3.517339e-01 | 0.454 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 3.545033e-01 | 0.450 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 3.550824e-01 | 0.450 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.552054e-01 | 0.450 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.552054e-01 | 0.450 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.572257e-01 | 0.447 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.572257e-01 | 0.447 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.572257e-01 | 0.447 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 3.577922e-01 | 0.446 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 3.577922e-01 | 0.446 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 3.577922e-01 | 0.446 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 3.577922e-01 | 0.446 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 3.577922e-01 | 0.446 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.577922e-01 | 0.446 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 3.577922e-01 | 0.446 | 0 | 0 |
| Defective HPRT1 disrupts guanine and hypoxanthine salvage | R-HSA-9734281 | 3.577922e-01 | 0.446 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.577922e-01 | 0.446 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 3.577922e-01 | 0.446 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 3.577922e-01 | 0.446 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 3.577922e-01 | 0.446 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 3.577922e-01 | 0.446 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 3.577922e-01 | 0.446 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.607652e-01 | 0.443 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.607652e-01 | 0.443 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.607652e-01 | 0.443 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.607652e-01 | 0.443 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.610574e-01 | 0.442 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 3.734243e-01 | 0.428 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.742328e-01 | 0.427 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.750550e-01 | 0.426 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.750550e-01 | 0.426 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 3.750550e-01 | 0.426 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 3.760855e-01 | 0.425 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.768462e-01 | 0.424 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 3.768462e-01 | 0.424 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.810483e-01 | 0.419 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.810483e-01 | 0.419 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.810483e-01 | 0.419 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.810483e-01 | 0.419 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 3.810483e-01 | 0.419 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 3.832321e-01 | 0.417 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 3.832321e-01 | 0.417 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 3.832321e-01 | 0.417 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 3.832321e-01 | 0.417 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 3.843330e-01 | 0.415 | 1 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 3.855449e-01 | 0.414 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 3.948497e-01 | 0.404 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.948497e-01 | 0.404 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 4.028405e-01 | 0.395 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 4.028405e-01 | 0.395 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 4.028405e-01 | 0.395 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 4.046697e-01 | 0.393 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 4.046697e-01 | 0.393 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.046697e-01 | 0.393 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 4.046697e-01 | 0.393 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.079638e-01 | 0.389 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 4.093417e-01 | 0.388 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 4.122353e-01 | 0.385 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 4.122353e-01 | 0.385 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.122353e-01 | 0.385 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.122353e-01 | 0.385 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.122353e-01 | 0.385 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.122353e-01 | 0.385 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.122353e-01 | 0.385 | 0 | 0 |
| GABA synthesis | R-HSA-888568 | 4.122353e-01 | 0.385 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.122353e-01 | 0.385 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.122353e-01 | 0.385 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.140515e-01 | 0.383 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.140515e-01 | 0.383 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 4.140515e-01 | 0.383 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.140515e-01 | 0.383 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 4.140515e-01 | 0.383 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.140515e-01 | 0.383 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.140515e-01 | 0.383 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.140515e-01 | 0.383 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 4.200776e-01 | 0.377 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 4.200776e-01 | 0.377 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 4.234811e-01 | 0.373 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.256710e-01 | 0.371 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.340897e-01 | 0.362 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 4.361161e-01 | 0.360 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 4.372258e-01 | 0.359 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 4.389401e-01 | 0.358 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.402876e-01 | 0.356 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 4.402893e-01 | 0.356 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 4.440808e-01 | 0.353 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.440808e-01 | 0.353 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 4.466218e-01 | 0.350 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 4.510349e-01 | 0.346 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 4.510349e-01 | 0.346 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 4.511176e-01 | 0.346 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.527360e-01 | 0.344 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 4.534511e-01 | 0.343 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.534511e-01 | 0.343 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 4.620659e-01 | 0.335 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.620659e-01 | 0.335 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 4.620659e-01 | 0.335 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 4.620659e-01 | 0.335 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 4.620659e-01 | 0.335 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.620659e-01 | 0.335 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 4.620659e-01 | 0.335 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 4.620659e-01 | 0.335 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 4.620659e-01 | 0.335 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 4.665202e-01 | 0.331 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 4.711428e-01 | 0.327 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 4.713670e-01 | 0.327 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 4.725894e-01 | 0.326 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 4.725894e-01 | 0.326 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 4.725894e-01 | 0.326 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.725894e-01 | 0.326 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 4.725894e-01 | 0.326 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 4.732326e-01 | 0.325 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.732326e-01 | 0.325 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.732326e-01 | 0.325 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 4.732326e-01 | 0.325 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 4.732326e-01 | 0.325 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 4.732326e-01 | 0.325 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 4.732326e-01 | 0.325 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 4.736606e-01 | 0.325 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.736606e-01 | 0.325 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.736606e-01 | 0.325 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 4.772024e-01 | 0.321 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.878597e-01 | 0.312 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.878597e-01 | 0.312 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 4.914707e-01 | 0.309 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 4.914707e-01 | 0.309 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 4.914707e-01 | 0.309 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 4.958484e-01 | 0.305 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.014398e-01 | 0.300 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.014398e-01 | 0.300 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.014398e-01 | 0.300 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.014398e-01 | 0.300 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 5.014398e-01 | 0.300 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 5.020227e-01 | 0.299 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 5.043838e-01 | 0.297 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 5.043838e-01 | 0.297 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 5.053319e-01 | 0.296 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.076746e-01 | 0.294 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.076746e-01 | 0.294 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 5.076746e-01 | 0.294 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 5.076746e-01 | 0.294 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.076746e-01 | 0.294 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.076746e-01 | 0.294 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.076746e-01 | 0.294 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.076746e-01 | 0.294 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 5.076746e-01 | 0.294 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 5.100644e-01 | 0.292 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 5.100644e-01 | 0.292 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 5.168840e-01 | 0.287 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 5.175567e-01 | 0.286 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 5.175567e-01 | 0.286 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 5.175567e-01 | 0.286 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 5.206934e-01 | 0.283 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 5.206934e-01 | 0.283 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 5.283429e-01 | 0.277 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 5.283429e-01 | 0.277 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.286531e-01 | 0.277 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 5.286531e-01 | 0.277 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.286531e-01 | 0.277 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 5.286531e-01 | 0.277 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.336985e-01 | 0.273 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 5.387500e-01 | 0.269 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 5.387500e-01 | 0.269 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 5.387500e-01 | 0.269 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 5.387500e-01 | 0.269 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 5.387500e-01 | 0.269 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 5.393387e-01 | 0.268 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.438446e-01 | 0.265 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 5.462815e-01 | 0.263 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 5.462815e-01 | 0.263 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 5.490660e-01 | 0.260 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 5.490660e-01 | 0.260 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.494189e-01 | 0.260 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 5.494189e-01 | 0.260 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.494189e-01 | 0.260 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.494189e-01 | 0.260 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 5.494189e-01 | 0.260 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 5.494189e-01 | 0.260 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 5.494189e-01 | 0.260 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 5.494189e-01 | 0.260 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 5.494189e-01 | 0.260 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 5.494189e-01 | 0.260 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 5.494189e-01 | 0.260 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 5.494189e-01 | 0.260 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 5.494189e-01 | 0.260 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 5.494189e-01 | 0.260 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 5.494189e-01 | 0.260 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.548384e-01 | 0.256 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 5.548384e-01 | 0.256 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.548384e-01 | 0.256 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 5.548384e-01 | 0.256 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.548384e-01 | 0.256 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 5.548384e-01 | 0.256 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 5.548384e-01 | 0.256 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 5.593988e-01 | 0.252 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 5.593988e-01 | 0.252 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 5.593988e-01 | 0.252 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 5.697590e-01 | 0.244 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 5.714903e-01 | 0.243 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 5.754597e-01 | 0.240 | 1 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 5.794788e-01 | 0.237 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 5.794788e-01 | 0.237 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 5.794788e-01 | 0.237 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 5.799742e-01 | 0.237 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 5.799742e-01 | 0.237 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 5.810554e-01 | 0.236 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 5.810554e-01 | 0.236 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.810554e-01 | 0.236 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 5.810554e-01 | 0.236 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.861128e-01 | 0.232 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 5.876259e-01 | 0.231 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 5.876259e-01 | 0.231 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 5.876259e-01 | 0.231 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 5.876259e-01 | 0.231 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 5.876259e-01 | 0.231 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 5.876259e-01 | 0.231 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 5.876259e-01 | 0.231 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 5.876259e-01 | 0.231 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 5.876259e-01 | 0.231 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.876259e-01 | 0.231 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 5.876259e-01 | 0.231 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 5.876259e-01 | 0.231 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 5.876259e-01 | 0.231 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 5.983938e-01 | 0.223 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.989708e-01 | 0.223 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.989708e-01 | 0.223 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.989708e-01 | 0.223 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.997454e-01 | 0.222 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 6.015346e-01 | 0.221 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 6.024698e-01 | 0.220 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 6.040503e-01 | 0.219 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 6.040503e-01 | 0.219 | 0 | 0 |
| PKA activation | R-HSA-163615 | 6.040503e-01 | 0.219 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 6.040503e-01 | 0.219 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 6.130612e-01 | 0.212 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 6.178602e-01 | 0.209 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.225953e-01 | 0.206 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.225953e-01 | 0.206 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.225953e-01 | 0.206 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 6.225953e-01 | 0.206 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 6.225953e-01 | 0.206 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.225953e-01 | 0.206 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.225953e-01 | 0.206 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 6.225953e-01 | 0.206 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 6.225953e-01 | 0.206 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 6.225953e-01 | 0.206 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 6.225953e-01 | 0.206 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.225953e-01 | 0.206 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 6.225953e-01 | 0.206 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 6.225953e-01 | 0.206 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.270657e-01 | 0.203 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.270657e-01 | 0.203 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.270657e-01 | 0.203 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 6.270657e-01 | 0.203 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.270657e-01 | 0.203 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.270657e-01 | 0.203 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 6.274109e-01 | 0.202 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 6.302134e-01 | 0.201 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 6.302134e-01 | 0.201 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 6.302134e-01 | 0.201 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 6.302134e-01 | 0.201 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 6.328728e-01 | 0.199 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 6.328728e-01 | 0.199 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 6.328728e-01 | 0.199 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 6.361364e-01 | 0.196 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 6.361364e-01 | 0.196 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 6.457508e-01 | 0.190 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 6.484068e-01 | 0.188 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.490271e-01 | 0.188 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.490271e-01 | 0.188 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.490271e-01 | 0.188 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 6.490271e-01 | 0.188 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 6.536352e-01 | 0.185 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 6.536352e-01 | 0.185 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 6.537927e-01 | 0.185 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 6.546011e-01 | 0.184 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 6.546011e-01 | 0.184 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 6.546011e-01 | 0.184 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 6.546011e-01 | 0.184 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.546011e-01 | 0.184 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 6.546011e-01 | 0.184 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.546011e-01 | 0.184 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.546011e-01 | 0.184 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 6.546011e-01 | 0.184 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 6.546011e-01 | 0.184 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 6.546011e-01 | 0.184 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 6.551242e-01 | 0.184 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 6.584878e-01 | 0.181 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 6.699477e-01 | 0.174 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.708257e-01 | 0.173 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 6.708257e-01 | 0.173 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.725808e-01 | 0.172 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 6.755075e-01 | 0.170 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 6.755075e-01 | 0.170 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 6.838944e-01 | 0.165 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 6.838944e-01 | 0.165 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 6.838944e-01 | 0.165 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 6.838944e-01 | 0.165 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 6.838944e-01 | 0.165 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 6.838944e-01 | 0.165 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 6.838944e-01 | 0.165 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 6.838944e-01 | 0.165 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 6.838944e-01 | 0.165 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 6.838944e-01 | 0.165 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 6.879010e-01 | 0.162 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 6.898460e-01 | 0.161 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 6.898460e-01 | 0.161 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.064514e-01 | 0.151 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 7.064514e-01 | 0.151 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.087450e-01 | 0.150 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.087450e-01 | 0.150 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 7.087450e-01 | 0.150 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.087450e-01 | 0.150 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.087450e-01 | 0.150 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 7.105870e-01 | 0.148 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 7.105870e-01 | 0.148 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.107050e-01 | 0.148 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 7.107050e-01 | 0.148 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 7.107050e-01 | 0.148 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.107050e-01 | 0.148 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.107050e-01 | 0.148 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.107050e-01 | 0.148 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.107050e-01 | 0.148 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.107050e-01 | 0.148 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.181963e-01 | 0.144 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.181963e-01 | 0.144 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 7.184107e-01 | 0.144 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 7.188378e-01 | 0.143 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 7.253594e-01 | 0.139 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 7.266710e-01 | 0.139 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 7.266710e-01 | 0.139 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 7.296363e-01 | 0.137 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 7.296692e-01 | 0.137 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 7.296692e-01 | 0.137 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 7.327597e-01 | 0.135 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.352430e-01 | 0.134 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 7.352430e-01 | 0.134 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 7.352430e-01 | 0.134 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 7.352430e-01 | 0.134 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.352430e-01 | 0.134 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 7.352430e-01 | 0.134 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.352430e-01 | 0.134 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 7.352430e-01 | 0.134 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.352430e-01 | 0.134 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 7.365247e-01 | 0.133 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.412769e-01 | 0.130 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.412769e-01 | 0.130 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 7.420965e-01 | 0.130 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 7.420965e-01 | 0.130 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 7.436531e-01 | 0.129 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 7.436531e-01 | 0.129 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.436531e-01 | 0.129 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 7.467228e-01 | 0.127 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.540846e-01 | 0.123 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.540846e-01 | 0.123 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 7.564545e-01 | 0.121 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 7.577011e-01 | 0.121 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 7.577011e-01 | 0.121 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 7.577011e-01 | 0.121 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 7.577011e-01 | 0.121 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.577011e-01 | 0.121 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.577011e-01 | 0.121 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.577011e-01 | 0.121 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 7.577011e-01 | 0.121 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 7.577011e-01 | 0.121 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 7.577011e-01 | 0.121 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 7.577011e-01 | 0.121 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.577011e-01 | 0.121 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.597223e-01 | 0.119 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.597223e-01 | 0.119 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 7.597223e-01 | 0.119 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.597223e-01 | 0.119 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 7.597223e-01 | 0.119 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 7.600963e-01 | 0.119 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 7.600963e-01 | 0.119 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.600963e-01 | 0.119 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 7.656385e-01 | 0.116 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 7.693746e-01 | 0.114 | 1 | 1 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 7.717138e-01 | 0.113 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 7.728920e-01 | 0.112 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.729669e-01 | 0.112 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 7.732556e-01 | 0.112 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 7.782554e-01 | 0.109 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 7.782554e-01 | 0.109 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 7.782554e-01 | 0.109 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 7.782554e-01 | 0.109 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 7.782554e-01 | 0.109 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 7.782554e-01 | 0.109 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 7.782554e-01 | 0.109 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 7.782554e-01 | 0.109 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 7.851230e-01 | 0.105 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 7.874679e-01 | 0.104 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 7.874679e-01 | 0.104 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.892538e-01 | 0.103 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.892538e-01 | 0.103 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.892538e-01 | 0.103 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 7.897975e-01 | 0.102 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 7.968034e-01 | 0.099 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 7.968034e-01 | 0.099 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 7.970672e-01 | 0.099 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 7.970672e-01 | 0.099 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 7.970672e-01 | 0.099 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 7.970672e-01 | 0.099 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 7.970672e-01 | 0.099 | 0 | 0 |
| Formation of the active cofactor, UDP-glucuronate | R-HSA-173599 | 7.970672e-01 | 0.099 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 7.970672e-01 | 0.099 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 7.970672e-01 | 0.099 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 7.970672e-01 | 0.099 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 7.970672e-01 | 0.099 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 7.970672e-01 | 0.099 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 7.970672e-01 | 0.099 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.027841e-01 | 0.095 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.049088e-01 | 0.094 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.079479e-01 | 0.093 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.142841e-01 | 0.089 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.142841e-01 | 0.089 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.142841e-01 | 0.089 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.142841e-01 | 0.089 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.142841e-01 | 0.089 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.142841e-01 | 0.089 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 8.142841e-01 | 0.089 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 8.142841e-01 | 0.089 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.142841e-01 | 0.089 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.142841e-01 | 0.089 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 8.142841e-01 | 0.089 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.142841e-01 | 0.089 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.148401e-01 | 0.089 | 1 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 8.185720e-01 | 0.087 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.185720e-01 | 0.087 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.202284e-01 | 0.086 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.262262e-01 | 0.083 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.275459e-01 | 0.082 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.275459e-01 | 0.082 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.275459e-01 | 0.082 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.275459e-01 | 0.082 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.300412e-01 | 0.081 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.300412e-01 | 0.081 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.300412e-01 | 0.081 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.300412e-01 | 0.081 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.300412e-01 | 0.081 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.300412e-01 | 0.081 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.300412e-01 | 0.081 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.300412e-01 | 0.081 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 8.300412e-01 | 0.081 | 0 | 0 |
| Mitochondrial Uncoupling | R-HSA-166187 | 8.300412e-01 | 0.081 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.300412e-01 | 0.081 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 8.309705e-01 | 0.080 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 8.352442e-01 | 0.078 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.365548e-01 | 0.078 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 8.428857e-01 | 0.074 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 8.432968e-01 | 0.074 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 8.432968e-01 | 0.074 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 8.444623e-01 | 0.073 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 8.444623e-01 | 0.073 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 8.444623e-01 | 0.073 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 8.444623e-01 | 0.073 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 8.444623e-01 | 0.073 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 8.444623e-01 | 0.073 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.444623e-01 | 0.073 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.444623e-01 | 0.073 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 8.444623e-01 | 0.073 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 8.444623e-01 | 0.073 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 8.512890e-01 | 0.070 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.512890e-01 | 0.070 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 8.515696e-01 | 0.070 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.527237e-01 | 0.069 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 8.576605e-01 | 0.067 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.576605e-01 | 0.067 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 8.576605e-01 | 0.067 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.576605e-01 | 0.067 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 8.576605e-01 | 0.067 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.576605e-01 | 0.067 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.576605e-01 | 0.067 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.589330e-01 | 0.066 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.589330e-01 | 0.066 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 8.594551e-01 | 0.066 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 8.634198e-01 | 0.064 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.644568e-01 | 0.063 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.688289e-01 | 0.061 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 8.697395e-01 | 0.061 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 8.697395e-01 | 0.061 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 8.697395e-01 | 0.061 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 8.697395e-01 | 0.061 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.723031e-01 | 0.059 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.768188e-01 | 0.057 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 8.768188e-01 | 0.057 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.776248e-01 | 0.057 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.776248e-01 | 0.057 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.776248e-01 | 0.057 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.798800e-01 | 0.056 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.798800e-01 | 0.056 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 8.807942e-01 | 0.055 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.807942e-01 | 0.055 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.858732e-01 | 0.053 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.862361e-01 | 0.052 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 8.866533e-01 | 0.052 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 8.909112e-01 | 0.050 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 8.909112e-01 | 0.050 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 8.909112e-01 | 0.050 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 8.909112e-01 | 0.050 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.909112e-01 | 0.050 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.920747e-01 | 0.050 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.925075e-01 | 0.049 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.936037e-01 | 0.049 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.936037e-01 | 0.049 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.936037e-01 | 0.049 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 8.980721e-01 | 0.047 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.980721e-01 | 0.047 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.001702e-01 | 0.046 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 9.001702e-01 | 0.046 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 9.001702e-01 | 0.046 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.001702e-01 | 0.046 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.001702e-01 | 0.046 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.001702e-01 | 0.046 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.034809e-01 | 0.044 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.076237e-01 | 0.042 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.086439e-01 | 0.042 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.086439e-01 | 0.042 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.144980e-01 | 0.039 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.163987e-01 | 0.038 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.163987e-01 | 0.038 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.163987e-01 | 0.038 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.163987e-01 | 0.038 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.185299e-01 | 0.037 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.198993e-01 | 0.036 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.234957e-01 | 0.035 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.234957e-01 | 0.035 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.234957e-01 | 0.035 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.234957e-01 | 0.035 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.234957e-01 | 0.035 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.234957e-01 | 0.035 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.240613e-01 | 0.034 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.299906e-01 | 0.032 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.299906e-01 | 0.032 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.299906e-01 | 0.032 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.299906e-01 | 0.032 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.305408e-01 | 0.031 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.306268e-01 | 0.031 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.306268e-01 | 0.031 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.306268e-01 | 0.031 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.311184e-01 | 0.031 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.311184e-01 | 0.031 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.338300e-01 | 0.030 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.352313e-01 | 0.029 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.359345e-01 | 0.029 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.359345e-01 | 0.029 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.359345e-01 | 0.029 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.359345e-01 | 0.029 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.359345e-01 | 0.029 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.379311e-01 | 0.028 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.413740e-01 | 0.026 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.413740e-01 | 0.026 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.413740e-01 | 0.026 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.413740e-01 | 0.026 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.431399e-01 | 0.025 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.442019e-01 | 0.025 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.442019e-01 | 0.025 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.463520e-01 | 0.024 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.463520e-01 | 0.024 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 9.463520e-01 | 0.024 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.463520e-01 | 0.024 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.463520e-01 | 0.024 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.481357e-01 | 0.023 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.481357e-01 | 0.023 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.509076e-01 | 0.022 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.509076e-01 | 0.022 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.509076e-01 | 0.022 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.509076e-01 | 0.022 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.509076e-01 | 0.022 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.522170e-01 | 0.021 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.531891e-01 | 0.021 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.536661e-01 | 0.021 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.550766e-01 | 0.020 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.588917e-01 | 0.018 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.588917e-01 | 0.018 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.601049e-01 | 0.018 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.613790e-01 | 0.017 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.623831e-01 | 0.017 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.638885e-01 | 0.016 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.640208e-01 | 0.016 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.641436e-01 | 0.016 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.655782e-01 | 0.015 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.683724e-01 | 0.014 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.685020e-01 | 0.014 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.685020e-01 | 0.014 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.691130e-01 | 0.014 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.705451e-01 | 0.013 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.711776e-01 | 0.013 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.711776e-01 | 0.013 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.711776e-01 | 0.013 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.714035e-01 | 0.013 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.724588e-01 | 0.012 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.736261e-01 | 0.012 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.736261e-01 | 0.012 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.736261e-01 | 0.012 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.736261e-01 | 0.012 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.743657e-01 | 0.011 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.753431e-01 | 0.011 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.758668e-01 | 0.011 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.771356e-01 | 0.010 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.779172e-01 | 0.010 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.779172e-01 | 0.010 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.779172e-01 | 0.010 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.788016e-01 | 0.009 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.795368e-01 | 0.009 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.797935e-01 | 0.009 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.797935e-01 | 0.009 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.797935e-01 | 0.009 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.803838e-01 | 0.009 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.811722e-01 | 0.008 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.815105e-01 | 0.008 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.817879e-01 | 0.008 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.817879e-01 | 0.008 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.819679e-01 | 0.008 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.830816e-01 | 0.007 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.843641e-01 | 0.007 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.845194e-01 | 0.007 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.849750e-01 | 0.007 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.858350e-01 | 0.006 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.865845e-01 | 0.006 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.870358e-01 | 0.006 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.878043e-01 | 0.005 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.878043e-01 | 0.005 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.909152e-01 | 0.004 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.909152e-01 | 0.004 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.909152e-01 | 0.004 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.921876e-01 | 0.003 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.923943e-01 | 0.003 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.926150e-01 | 0.003 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.927200e-01 | 0.003 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.927723e-01 | 0.003 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.927723e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.930410e-01 | 0.003 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.936327e-01 | 0.003 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.938160e-01 | 0.003 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.939747e-01 | 0.003 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.941742e-01 | 0.003 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.944488e-01 | 0.002 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.946294e-01 | 0.002 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.946696e-01 | 0.002 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.958215e-01 | 0.002 | 0 | 0 |
| Glucuronidation | R-HSA-156588 | 9.959173e-01 | 0.002 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.961379e-01 | 0.002 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.964720e-01 | 0.002 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.966388e-01 | 0.001 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.967018e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.968731e-01 | 0.001 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.973826e-01 | 0.001 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.975239e-01 | 0.001 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.976053e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.977791e-01 | 0.001 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.978090e-01 | 0.001 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.978090e-01 | 0.001 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.983222e-01 | 0.001 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.985956e-01 | 0.001 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.987125e-01 | 0.001 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.987142e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.987152e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.988246e-01 | 0.001 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.989593e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.990162e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.990497e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.990999e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.991111e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.992167e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.992167e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.993109e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.993852e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.995584e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.996090e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.996305e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.997647e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.997682e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.997834e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.998612e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999011e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999185e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999587e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999694e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999740e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999796e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999835e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999887e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999892e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.999908e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999949e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999957e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999983e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999988e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999989e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999989e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999995e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999995e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999996e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999996e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |